BAYLOR RESEARCH INSTITUTE
Cite this
Plain text BAYLOR RESEARCH INSTITUTE. furp.org, nonprofit organization profile, tax years 2009–2024. https://furp.org/org/baylor-research-institute-751921898. Retrieved 2026-11-02.
APA furp.org. (n.d.). BAYLOR RESEARCH INSTITUTE [Nonprofit organization profile; tax years 2009–2024]. Retrieved November 2, 2026, from https://furp.org/org/baylor-research-institute-751921898
MLA “BAYLOR RESEARCH INSTITUTE.” furp.org, tax years 2009–2024, https://furp.org/org/baylor-research-institute-751921898. Accessed 2 Nov. 2026.
Retrieved 2026-11-02; covers tax years 2009–2024. Data: furp.org, CC BY 4.0.
2024 · Form 990 · revenue $89.5M · expenses $85.9M · assets $191.9M
- Also known as
- Baylor Scott & White Research Institute
- EIN
- 75-1921898
- Address
- 301 N WASHINGTON AVE, DALLAS, TX 75246-1754
- Website
- www.bswhealth.com
- NTEE code
- H900
- Exempt type
- 501(c)(3): charitable, religious, educational, scientific or literary (corporation)
- Ruling date
- February 1984 (when the IRS recognized its exemption)
- IRS status
- Exempt (unconditional) (IRS Business Master File) IRS data ↗
- Tax-deductible donations
- Yes: listed in IRS Publication 78 (public charity) Pub 78 ↗
- Foundation status
- Hospital or medical research organization
- Cross-check
- ProPublica Nonprofit Explorer
Mission
To improve the care and well being of our community, nationally and internationally, through innovative clinically relevant research that is consistent with the mission, vision and values of Baylor Scott & White Health (BSWH).
Each tax year counts once: when a return was amended, only the latest return for that period is used below (superseded returns stay listed, greyed, under Finances).
People paid by the organization
44 people paid across every filing: current people first, then by total pay from this organization. Organizations counts every nonprofit each person appears on.
| Name | Latest title | Years | Latest year pay | Total pay from here | Organizations |
|---|---|---|---|---|---|
| Steven Newton | Trustee | 2017-2024 | $2,977,455 | $17,453,261 | 8 |
| Alejandro Arroliga MD | Trustee | 2018-2024 | $2,669,383 | $14,728,818 | 15 |
| Michael J Mack MD | Trustee/Chair | 2019-2024 | $626,578 | $4,408,082 | 3 |
| Gerard Zurawski | Dir Institute Immun Rsrch | 2011-2024 | $340,652 | $4,326,121 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 2014-2024 | $358,014 | $3,254,834 | 1 |
| Amy Martin | VP CFO | 2019-2024 | $500,711 | $2,614,946 | 6 |
| Alan Stevens | Research Center Dir | 2017-2024 | $332,495 | $2,481,782 | 1 |
| Javed Butler MD | Trustee/President/CEO | 2021-2024 | $915,692 | $2,455,698 | 1 |
| Jennifer Thomas | VP Research Operations | 2018-2024 | $370,220 | $2,306,317 | 1 |
| Mitch Dean | Secretary | 2021-2024 | $506,043 | $1,783,670 | 1 |
| Simon Driver | Research Center Dir | 2020-2024 | $315,928 | $1,523,821 | 1 |
| Suzy Gulliver | Research Center Dir | 2020-2024 | $321,505 | $1,184,226 | 2 |
| Elisa Priest | Director Clinical Informatics | 2021-2024 | $395,887 | $1,005,829 | 1 |
| John McWhorter (former) | Trustee | 2009-2017 | $2,224,582 | $13,923,632 | 17 |
| Michael Ramsay MD (former) | Former Officer | 2009-2021 | $135,063 | $8,198,740 | 2 |
| Paul Convery MD (former) | Director | 2009-2015 | $165,696 | $5,758,216 | 2 |
| Joel Allison (former) | Director | 2009-2010 | $3,076,896 | $5,351,721 | 10 |
| Robert A Probe MD (former) | Trustee (thru 2/21/19) | 2016-2018 | $1,617,017 | $4,630,165 | 10 |
| Jaime Walkowiak (former) | Sect/SVP Chief Rsch | 2011-2020 | $507,823 | $4,085,150 | 1 |
| Renee Day (former) | VP CFO (thru 7/22/19) | 2009-2019 | $270,176 | $2,823,011 | 2 |
| Maria Pascual (former) | Director Clinical Research | 2009-2016 | $327,331 | $2,717,779 | 1 |
| Ajay Goel (former) | Director Research | 2013-2019 | $267,623 | $2,409,478 | 1 |
| Bernard Brigonnet (former) | Former Officer | 2009-2012 | $230,260 | $1,597,000 | 1 |
| Anna Palucka (former) | Clinical Mgmt Researcher | 2009-2013 | $329,019 | $1,364,038 | 1 |
| Yong-Jun Liu (former) | Chief Scientific Officer | 2012-2013 | $671,295 | $1,357,551 | 1 |
| Shahid Shafi (former) | Medical Director | 2012-2017 | $252,275 | $1,097,452 | 1 |
| Rowland Robinson (former) | Director | 2009-2010 | $500,676 | $1,019,852 | 2 |
| Moshe Levy MD (former) | Medical Director | 2014-2017 | $243,461 | $997,285 | 1 |
| Alan Menter MD (former) | Medical Director | 2009-2011 | $361,819 | $991,880 | 1 |
| Shinichi Matsumoto MD PhD (former) | Director Clin Rsch Serv | 2009-2011 | $311,326 | $907,958 | 1 |
| Jacques Banchereau (former) | Director Inst Immun Rsch | 2009-2010 | $370,169 | $850,450 | 1 |
| Paul Grayburn MD (former) | Medical Director | 2018-2019 | $299,292 | $612,865 | 1 |
| Teodoro Bottiglieri (former) | Dir Institute Immun Rsrch | 2021-2022 | $277,037 | $586,342 | 1 |
| Clement Boland MD (former) | Medical Director | 2014 | $359,535 | $359,535 | 1 |
| Jennifer Fox (former) | Secretary/VP Rsch Ops | 2020 | $292,304 | $292,304 | 1 |
| Tawanda Gumbo (former) | Investigator | 2015 | $268,699 | $268,699 | 1 |
| Young-Jun Liu (former) | Chief Scientific Officer | 2011 | $243,123 | $243,123 | 1 |
| Lawrence Sweetman (former) | Director Mass Spec Lab | 2012 | $235,154 | $235,154 | 1 |
| Brenda Chapman (former) | VP Research Foundation | 2009 | $197,746 | $197,746 | 2 |
| Michael Mathisen (former) | Former Officer | 2009 | $193,973 | $193,973 | 1 |
| Victoria Allgood (former) | VP Research Operations | 2009-2010 | $108,100 | $108,100 | 1 |
| Zelig H Lieberman MD (former) | Director | 2009-2010 | $35,439 | $71,217 | 1 |
| Erle Nye (former) | Trustee | 2009-2018 | $0 | $1,456 | 22 |
| Ronald D Murff (former) | Trustee/Chair | 2011-2018 | $0 | $240 | 1 |
Officers and directors, no compensation reported
13 people listed on the returns with $0 (or no amount) in every compensation column: current people first. Hours are as filed on the latest return each person appears on.
| Name | Latest title | Years | Hrs/wk (latest) | Compensation | Organizations |
|---|---|---|---|---|---|
| Kent Eastman (former) | Trustee | 2011-2018 | 1 | $0 reported | 3 |
| Shelley Conroy (former) | Trustee | 2016-2018 | 1 | $0 reported | 1 |
| Louis Beecherl (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| Darren Blanton (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| John W Creecy (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| Tiffani Evans (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| Robert Kane Phd (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| Robert Lavie (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| R Steven Paulson MD (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| Milla Perry Jones (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| George Race MD (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| Jack Vaughn (former) | Director | 2009-2010 | 1 | $0 reported | 1 |
| Milton Levy Jr (former) | Director | 2009 | 1 | $0 reported | 1 |
People by year
2024 · 13 people listed · 13 paid, $10.6M · 594 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Steven Newton | Trustee | 1 | $0 | $2,931,092 | $46,363 | $2,977,455 | 8 |
| Alejandro Arroliga MD | Trustee | 1 | $0 | $2,620,998 | $48,385 | $2,669,383 | 15 |
| Javed Butler MD | Trustee/President/CEO | 40 | $806,185 | $0 | $109,507 | $915,692 | 1 |
| Michael J Mack MD | Trustee/Chair | 1 | $0 | $605,049 | $21,529 | $626,578 | 3 |
| Mitch Dean | Secretary | 1 | $0 | $444,345 | $61,698 | $506,043 | 1 |
| Amy Martin | VP CFO | 1 | $0 | $423,050 | $77,661 | $500,711 | 6 |
| Elisa Priest | Director Clinical Informatics | 40 | $327,925 | $0 | $67,962 | $395,887 | 1 |
| Jennifer Thomas | VP Research Operations | 40 | $330,334 | $0 | $39,886 | $370,220 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $309,167 | $0 | $48,847 | $358,014 | 1 |
| Gerard Zurawski | Dir Institute Immun Rsrch | 40 | $315,598 | $0 | $25,054 | $340,652 | 1 |
| Alan Stevens | Research Center Dir | 40 | $295,784 | $0 | $36,711 | $332,495 | 1 |
| Suzy Gulliver | Research Center Dir | 40 | $284,849 | $0 | $36,656 | $321,505 | 2 |
| Simon Driver | Research Center Dir | 40 | $277,664 | $0 | $38,264 | $315,928 | 1 |
2023 · 13 people listed · 13 paid, $12.9M · 572 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Steven Newton | Trustee | 1 | $0 | $3,595,037 | $631,482 | $4,226,519 | 8 |
| Alejandro Arroliga MD | Trustee | 1 | $0 | $3,306,664 | $638,925 | $3,945,589 | 15 |
| Javed Butler MD | Trustee/President/CEO | 40 | $753,435 | $0 | $90,922 | $844,357 | 1 |
| Michael J Mack MD | Trustee/Chair | 1 | $0 | $605,049 | $20,779 | $625,828 | 3 |
| Mitch Dean | Secretary | 1 | $0 | $406,852 | $57,645 | $464,497 | 1 |
| Amy Martin | VP CFO | 1 | $0 | $389,259 | $75,161 | $464,420 | 6 |
| Jennifer Thomas | VP Research Operations | 40 | $312,494 | $0 | $42,848 | $355,342 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $299,147 | $0 | $45,848 | $344,995 | 1 |
| Gerard Zurawski | Dir Institute Immun Rsrch | 40 | $315,436 | $0 | $24,904 | $340,340 | 1 |
| Alan Stevens | Research Center Dir | 40 | $297,403 | $0 | $32,849 | $330,252 | 1 |
| Elisa Priest | Director Clinical Informatics | 40 | $277,993 | $0 | $50,898 | $328,891 | 1 |
| Simon Driver | Research Center Dir | 40 | $289,292 | $0 | $36,234 | $325,526 | 1 |
| Suzy Gulliver | Research Center Dir | 40 | $268,706 | $0 | $35,432 | $304,138 | 2 |
2022 · 13 people listed · 13 paid, $8.6M · 570 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Alejandro Arroliga MD | Trustee | 1 | $0 | $1,677,582 | $438,520 | $2,116,102 | 15 |
| Steven Newton | Trustee | 1 | $0 | $1,595,379 | $401,848 | $1,997,227 | 8 |
| Michael J Mack MD | Trustee/Chair | 1 | $0 | $705,092 | $19,486 | $724,578 | 3 |
| Javed Butler MD | Trustee/President/CEO | 40 | $631,586 | $0 | $64,063 | $695,649 | 1 |
| Amy Martin | VP CFO | 1 | $0 | $373,384 | $72,515 | $445,899 | 6 |
| Mitch Dean | Secretary | 1 | $0 | $371,817 | $53,564 | $425,381 | 1 |
| Gerard Zurawski | Dir Institute Immun Rsrch | 40 | $319,620 | $0 | $15,779 | $335,399 | 1 |
| Jennifer Thomas | VP Research Operations | 40 | $289,273 | $0 | $41,468 | $330,741 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $276,951 | $0 | $44,778 | $321,729 | 1 |
| Alan Stevens | Research Center Dir | 40 | $293,674 | $0 | $26,640 | $320,314 | 1 |
| Simon Driver | Research Center Dir | 40 | $275,746 | $0 | $34,435 | $310,181 | 1 |
| Suzy Gulliver | Research Center Dir | 40 | $253,128 | $0 | $33,479 | $286,607 | 2 |
| Teodoro Bottiglieri | Dir Institute Immun Rsrch | 40 | $255,349 | $0 | $21,688 | $277,037 | 1 |
2021 · 14 people listed · 13 paid, $7.6M · 534 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Steven Newton | Trustee | 1 | $0 | $1,524,850 | $361,208 | $1,886,058 | 8 |
| Alejandro Arroliga MD | Trustee | 1 | $0 | $1,473,245 | $410,789 | $1,884,034 | 15 |
| Michael J Mack MD | Trustee/Chair/Pres/CEO | 1 | $0 | $605,112 | $18,716 | $623,828 | 3 |
| Amy Martin | VP CFO | 1 | $0 | $365,089 | $71,004 | $436,093 | 6 |
| Mitch Dean | Secretary | 1 | $0 | $337,530 | $50,219 | $387,749 | 1 |
| Jennifer Thomas | VP Research Operations | 40 | $324,196 | $0 | $53,033 | $377,229 | 1 |
| Gerard Zurawski | Dir Institute Immun Rsrch | 40 | $316,752 | $0 | $17,283 | $334,035 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $274,508 | $0 | $43,231 | $317,739 | 1 |
| Alan Stevens | Research Center Dir | 40 | $290,804 | $0 | $25,269 | $316,073 | 1 |
| Teodoro Bottiglieri | Dir Institute Immun Rsrch | 40 | $286,018 | $0 | $23,287 | $309,305 | 1 |
| Simon Driver | Research Center Dir | 40 | $247,955 | $0 | $33,380 | $281,335 | 1 |
| Elisa Priest | Director Clinical Informatics | 40 | $245,777 | $0 | $35,274 | $281,051 | 1 |
| Michael Ramsay MD | Former Officer | 0 | $0 | $126,950 | $8,113 | $135,063 | 2 |
| Javed Butler MD | Trustee/Chair/Pres/CEO (eff 3/25/22) | 40 | $0 | $0 | $0 | $0 | 1 |
2020 · 13 people listed · 13 paid, $7.8M · 519 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Steven Newton | Trustee | 1 | $0 | $1,621,572 | $321,037 | $1,942,609 | 8 |
| Alejandro Arroliga MD | Trustee | 1 | $0 | $1,269,131 | $290,153 | $1,559,284 | 15 |
| Michael J Mack MD | Trustee/Chair/President/CEO | 1 | $0 | $760,055 | $18,212 | $778,267 | 3 |
| Michael Ramsay MD | President/CEO | 10 | $0 | $488,167 | $36,693 | $524,860 | 2 |
| Jaime Walkowiak | Sect/SVP Chief Rsch | 40 | $437,751 | $0 | $70,072 | $507,823 | 1 |
| Amy Martin | VP CFO | 1 | $0 | $350,947 | $57,939 | $408,886 | 6 |
| Gerard Zurawski | Dir Institute Immun Rsrch | 40 | $316,265 | $0 | $16,930 | $333,195 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $271,138 | $0 | $49,484 | $320,622 | 1 |
| Alan Stevens | Research Center Dir | 40 | $288,314 | $0 | $24,679 | $312,993 | 1 |
| Jennifer Thomas | VP Research Operations | 40 | $255,572 | $0 | $46,557 | $302,129 | 1 |
| Jennifer Fox | Secretary/VP Rsch Ops | 40 | $261,326 | $0 | $30,978 | $292,304 | 1 |
| Simon Driver | Research Center Dir | 40 | $257,827 | $0 | $33,024 | $290,851 | 1 |
| Suzy Gulliver | Investigator | 40 | $239,416 | $0 | $32,560 | $271,976 | 2 |
2019 · 13 people listed · 13 paid, $7.6M · 623 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Steven Newton | Trustee | 1 | $0 | $1,292,126 | $302,447 | $1,594,573 | 8 |
| Alejandro Arroliga MD | Trustee | 1 | $0 | $1,195,061 | $144,557 | $1,339,618 | 15 |
| Michael J Mack MD | Trustee/Chair | 1 | $0 | $1,010,708 | $18,295 | $1,029,003 | 3 |
| Michael Ramsay MD | President/CEO | 10 | $0 | $611,119 | $36,388 | $647,507 | 2 |
| Jaime Walkowiak | Secretary/SVP Chief Research Exec | 40 | $487,836 | $0 | $69,192 | $557,028 | 1 |
| Amy Martin | VP CFO (eff 10/22/19) | 1 | $0 | $320,280 | $38,657 | $358,937 | 6 |
| Gerard Zurawski | Director Inst. Immunology | 40 | $316,745 | $0 | $16,686 | $333,431 | 1 |
| Paul Grayburn MD | Medical Director | 29 | $222,600 | $76,692 | $0 | $299,292 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Office | 40 | $251,050 | $0 | $47,889 | $298,939 | 1 |
| Alan Stevens | Dir Comm & Applied Health | 40 | $267,673 | $0 | $24,047 | $291,720 | 1 |
| Jennifer Thomas | VP Research Operations | 40 | $248,140 | $0 | $39,508 | $287,648 | 1 |
| Renee Day | VP CFO (thru 7/22/19) | 40 | $221,043 | $0 | $49,133 | $270,176 | 2 |
| Ajay Goel | Director Research | 40 | $259,063 | $0 | $8,560 | $267,623 | 1 |
2018 · 16 people listed · 12 paid, $7.6M · 620 employees · 4 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Robert A Probe MD | Trustee (thru 2/21/19) | 1 | $0 | $1,280,054 | $336,963 | $1,617,017 | 10 |
| Steven Newton | Trustee | 1 | $0 | $1,177,219 | $277,323 | $1,454,542 | 8 |
| Alejandro Arroliga MD | Trustee (eff 2/21/19) | 1 | $0 | $1,080,191 | $134,617 | $1,214,808 | 15 |
| Michael Ramsay MD | President/CEO | 10 | $0 | $606,457 | $33,419 | $639,876 | 2 |
| Jaime Walkowiak | Secretary/SVP COO | 40 | $454,073 | $0 | $66,721 | $520,794 | 1 |
| Ajay Goel | Director Research | 40 | $304,051 | $0 | $36,998 | $341,049 | 1 |
| Renee Day | VP Finance/CFO | 40 | $272,088 | $0 | $63,751 | $335,839 | 2 |
| Gerard Zurawski | Director Inst. Immunology Research | 40 | $302,555 | $0 | $14,539 | $317,094 | 1 |
| Paul Grayburn MD | Medical Director | 24 | $216,600 | $81,009 | $15,964 | $313,573 | 1 |
| Alan Stevens | Dir Comm & Applied Health Rsch | 40 | $268,307 | $0 | $24,250 | $292,557 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $241,630 | $0 | $45,421 | $287,051 | 1 |
| Jennifer Thomas | VP Research Operations | 40 | $240,867 | $0 | $42,141 | $283,008 | 1 |
| Shelley Conroy | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
| Kent Eastman | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Ronald D Murff | Trustee/Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Erle Nye | Trustee | 1 | $0 | $0 | $0 | $0 | 22 |
2017 · 16 people listed · 12 paid, $8.5M · 703 employees · 4 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| John McWhorter | Trustee | 1 | $0 | $1,793,414 | $431,168 | $2,224,582 | 17 |
| Robert A Probe MD | Trustee | 1 | $0 | $1,310,630 | $272,222 | $1,582,852 | 10 |
| Steven Newton | Trustee | 1 | $0 | $1,101,643 | $272,635 | $1,374,278 | 8 |
| Michael Ramsay MD | President/CEO | 10 | $0 | $601,804 | $32,061 | $633,865 | 2 |
| Jaime Walkowiak | Secretary/SVP COO | 40 | $433,460 | $0 | $70,682 | $504,142 | 1 |
| Ajay Goel | Director Research | 40 | $451,468 | $0 | $36,428 | $487,896 | 1 |
| Renee Day | VP Finance/CFO | 40 | $254,755 | $0 | $65,957 | $320,712 | 2 |
| Gerard Zurawski | Director Inst. Immunology Research | 40 | $292,555 | $0 | $14,266 | $306,821 | 1 |
| Alan Stevens | Dir Comm & Applied Health Rsch | 40 | $235,380 | $26,987 | $23,011 | $285,378 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $222,514 | $0 | $47,361 | $269,875 | 1 |
| Shahid Shafi | Medical Director | 40 | $234,940 | $5,588 | $11,747 | $252,275 | 1 |
| Moshe Levy MD | Medical Director | 22 | $232,931 | $0 | $10,530 | $243,461 | 1 |
| Kent Eastman | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Ronald D Murff | Trustee/Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Erle Nye | Trustee | 1 | $0 | $0 | $0 | $0 | 22 |
| Shelley Conroy | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
2016 · 15 people listed · 11 paid, $6.7M · 494 employees · 4 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| John McWhorter | Trustee | 1 | $0 | $1,634,088 | $405,660 | $2,039,748 | 17 |
| Robert A Probe MD | Trustee | 1 | $0 | $1,262,746 | $167,550 | $1,430,296 | 10 |
| Michael Ramsay MD | President | 10 | $0 | $631,884 | $19,629 | $651,513 | 2 |
| Jaime Walkowiak | Secretary/SVP COO | 40 | $435,881 | $0 | $64,432 | $500,313 | 1 |
| Ajay Goel | Director Research | 40 | $323,658 | $0 | $38,157 | $361,815 | 1 |
| Maria Pascual | Director Clinical Research | 40 | $318,701 | $0 | $8,630 | $327,331 | 1 |
| Renee Day | VP Finance/CFO | 40 | $255,913 | $0 | $62,748 | $318,661 | 2 |
| Gerard Zurawski | Director Inst. Immunology | 40 | $282,127 | $0 | $13,787 | $295,914 | 1 |
| Shahid Shafi | Medical Director | 40 | $280,492 | $0 | $13,791 | $294,283 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $222,886 | $0 | $50,138 | $273,024 | 1 |
| Moshe Levy MD | Medical Director | 22 | $250,813 | $0 | $481 | $251,294 | 1 |
| Kent Eastman | Trustee | 1 | $0 | $0 | $0 | $0 | 3 |
| Ronald D Murff | Trustee/Chair | 1 | $0 | $0 | $0 | $0 | 1 |
| Erle Nye | Trustee | 1 | $0 | $0 | $0 | $0 | 22 |
| Shelley Conroy | Trustee | 1 | $0 | $0 | $0 | $0 | 1 |
2015 · 14 people listed · 11 paid, $5.7M · 492 employees · 3 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| John McWhorter | Director | 1 | $0 | $1,907,354 | $381,368 | $2,288,722 | 17 |
| Michael Ramsay MD | President | 10 | $0 | $597,525 | $21,266 | $618,791 | 2 |
| Jaime Walkowiak | Secretary/SVP COO | 40 | $370,010 | $0 | $58,066 | $428,076 | 1 |
| Ajay Goel | Director Research | 40 | $353,875 | $0 | $37,933 | $391,808 | 1 |
| Maria Pascual | Director Clinical Research Services | 40 | $339,782 | $0 | $9,662 | $349,444 | 1 |
| Renee Day | VP Finance/CFO | 40 | $266,720 | $0 | $55,701 | $322,421 | 2 |
| Gerard Zurawski | Director Inst. Immunology Research | 40 | $296,980 | $0 | $13,786 | $310,766 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $223,739 | $0 | $45,137 | $268,876 | 1 |
| Tawanda Gumbo | Investigator | 40 | $232,503 | $0 | $36,196 | $268,699 | 1 |
| Moshe Levy MD | Medical Director | 22 | $251,040 | $0 | $482 | $251,522 | 1 |
| Paul Convery MD | Director | 1 | $0 | $165,696 | $0 | $165,696 | 2 |
| Kent Eastman | Director | 1 | $0 | $0 | $0 | $0 | 3 |
| Ronald D Murff | Director/Chairman | 1 | $0 | $0 | $0 | $0 | 1 |
| Erle Nye | Director | 1 | $0 | $0 | $0 | $0 | 22 |
2014 · 14 people listed · 11 paid, $5.1M · 459 employees · 3 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| John McWhorter | Director | 1 | $0 | $1,592,088 | $271,801 | $1,863,889 | 17 |
| Michael Ramsay MD | President | 10 | $0 | $708,851 | $84,610 | $793,461 | 2 |
| Jaime Walkowiak | VP Research Ops/Bus Devel/Secretary | 40 | $315,836 | $0 | $50,076 | $365,912 | 1 |
| Clement Boland MD | Medical Director | 20 | $252,486 | $32,064 | $74,985 | $359,535 | 1 |
| Ajay Goel | Director Research Center | 40 | $292,706 | $0 | $33,773 | $326,479 | 1 |
| Maria Pascual | Director Clinical Research Services | 40 | $309,845 | $0 | $8,548 | $318,393 | 1 |
| Gerard Zurawski | Director Inst. Immunology Research | 40 | $293,403 | $0 | $13,489 | $306,892 | 1 |
| Renee Day | VP Finance/CFO | 40 | $224,253 | $0 | $39,881 | $264,134 | 2 |
| Moshe Levy MD | Medical Director | 20 | $124,430 | $126,030 | $548 | $251,008 | 1 |
| Elizabeth Cothran | VP Chief Regulatory Officer | 40 | $167,546 | $0 | $26,424 | $193,970 | 1 |
| Paul Convery MD | Director | 1 | $0 | $51,900 | $0 | $51,900 | 2 |
| Erle Nye | Director | 1 | $0 | $0 | $0 | $0 | 22 |
| Kent Eastman | Director | 1 | $0 | $0 | $0 | $0 | 3 |
| Ronald D Murff | Chairman | 1 | $0 | $0 | $0 | $0 | 1 |
2013 · 14 people listed · 12 paid, $6.3M · 447 employees · 9 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Paul Convery MD | Director | 1 | $0 | $1,041,418 | $239,828 | $1,281,246 | 2 |
| John McWhorter | Director | 1 | $0 | $970,303 | $230,554 | $1,200,857 | 17 |
| Michael Ramsay MD | President | 10 | $186,505 | $559,512 | $73,084 | $819,101 | 2 |
| Yong-Jun Liu | Chief Scientific Officer | 40 | $586,430 | $0 | $84,865 | $671,295 | 1 |
| Maria Pascual | Director Clinical Research | 40 | $631,978 | $0 | $13,784 | $645,762 | 1 |
| Anna Palucka | Clinical Mgmt Researcher | 40 | $301,671 | $0 | $27,348 | $329,019 | 1 |
| Shahid Shafi | Principal Investigator | 24 | $236,138 | $62,000 | $12,260 | $310,398 | 1 |
| Gerard Zurawski | Program Director | 40 | $271,572 | $0 | $12,292 | $283,864 | 1 |
| Jaime Walkowiak | VP Research Ops/Bus Devel | 40 | $232,198 | $0 | $25,852 | $258,050 | 1 |
| Ajay Goel | Program Director | 40 | $207,947 | $0 | $24,861 | $232,808 | 1 |
| Renee Day | VP-Finance/CFO | 40 | $196,069 | $0 | $30,365 | $226,434 | 2 |
| Erle Nye | Director | 1 | $0 | $1,456 | $0 | $1,456 | 22 |
| Kent Eastman | Director | 1 | $0 | $0 | $0 | $0 | 3 |
| Ronald D Murff | Chairman | 1 | $0 | $0 | $0 | $0 | 1 |
2012 · 15 people listed · 12 paid, $5.7M · 414 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Paul Convery MD | Director | 1 | $0 | $947,191 | $192,418 | $1,139,609 | 2 |
| John McWhorter | Director | 1 | $0 | $924,131 | $197,133 | $1,121,264 | 17 |
| Michael Ramsay MD | President | 10 | $0 | $662,166 | $83,748 | $745,914 | 2 |
| Yong-Jun Liu | Chief Scientific Officer | 40 | $610,053 | $0 | $76,203 | $686,256 | 1 |
| Maria Pascual | Director Clinical Research | 40 | $262,446 | $0 | $14,822 | $277,268 | 1 |
| Jaime Walkowiak | VP Research Ops/Bus Devel | 40 | $223,382 | $0 | $37,804 | $261,186 | 1 |
| Anna Palucka | Clinical Mgmt Researcher | 40 | $233,619 | $0 | $27,359 | $260,978 | 1 |
| Shahid Shafi | Principal Investigator | 22 | $228,575 | $0 | $11,921 | $240,496 | 1 |
| Gerard Zurawski | Program Director | 40 | $226,798 | $0 | $11,803 | $238,601 | 1 |
| Lawrence Sweetman | Director Mass Spec Lab | 40 | $213,401 | $0 | $21,753 | $235,154 | 1 |
| Bernard Brigonnet | Former Officer | 40 | $186,059 | $0 | $44,201 | $230,260 | 1 |
| Renee Day | VP-Finance | 40 | $195,228 | $0 | $32,750 | $227,978 | 2 |
| Erle Nye | Director | 1 | $0 | $0 | $0 | $0 | 22 |
| Kent Eastman | Director | 1 | $0 | $0 | $0 | $0 | 3 |
| Ronald D Murff | Chairman | 1 | $0 | $0 | $0 | $0 | 1 |
2011 · 15 people listed · 13 paid, $5.5M · 346 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Paul Convery MD | Director | 1 | $0 | $961,649 | $204,376 | $1,166,025 | 2 |
| John McWhorter | Director | 1 | $0 | $825,923 | $196,607 | $1,022,530 | 17 |
| Michael Ramsay MD | President | 10 | $0 | $615,856 | $85,149 | $701,005 | 2 |
| Bernard Brigonnet | Chief Operating Officer | 40 | $410,243 | $0 | $72,151 | $482,394 | 1 |
| Alan Menter MD | Medical Director | 28 | $334,847 | $0 | $26,972 | $361,819 | 1 |
| Shinichi Matsumoto MD PhD | Director Clin Rsch Serv | 40 | $277,215 | $0 | $34,111 | $311,326 | 1 |
| Maria Pascual | Director Clinical Research Services | 40 | $272,985 | $0 | $16,190 | $289,175 | 1 |
| Anna Palucka | Clinical Mgmt Researcher | 40 | $244,828 | $0 | $28,091 | $272,919 | 1 |
| Gerard Zurawski | Program Director | 40 | $237,796 | $0 | $11,321 | $249,117 | 1 |
| Young-Jun Liu | Chief Scientific Officer | 40 | $206,505 | $0 | $36,618 | $243,123 | 1 |
| Renee Day | VP-Finance | 40 | $187,047 | $0 | $35,171 | $222,218 | 2 |
| Jaime Walkowiak | VP Research Ops/Bus Devel | 40 | $6,657 | $149,141 | $26,028 | $181,826 | 1 |
| Ronald D Murff | Chairman | 1 | $0 | $240 | $0 | $240 | 1 |
| Erle Nye | Director | 1 | $0 | $0 | $0 | $0 | 22 |
| Kent Eastman | Director | 1 | $0 | $0 | $0 | $0 | 3 |
2010 · 25 people listed · 14 paid, $8.9M · 333 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Joel Allison | Director | 1 | $0 | $2,662,323 | $414,573 | $3,076,896 | 10 |
| John McWhorter | Director | 1 | $0 | $1,142,450 | $155,515 | $1,297,965 | 17 |
| Paul Convery MD | Director | 1 | $0 | $821,900 | $173,521 | $995,421 | 2 |
| Michael Ramsay MD | President | 15 | $0 | $602,720 | $70,303 | $673,023 | 2 |
| Rowland Robinson | Director | 1 | $0 | $435,370 | $65,306 | $500,676 | 2 |
| Bernard Brigonnet | Chief Operating Officer | 40 | $413,664 | $0 | $58,522 | $472,186 | 1 |
| Jacques Banchereau | Director Inst Immun Rsch | 40 | $309,274 | $0 | $60,895 | $370,169 | 1 |
| Alan Menter MD | Medical Director | 28 | $302,521 | $0 | $12,613 | $315,134 | 1 |
| Shinichi Matsumoto MD PhD | Director Clin Rsch Serv | 40 | $271,021 | $0 | $28,010 | $299,031 | 1 |
| Maria Pascual | Clinical Mgmt Researcher | 40 | $257,941 | $0 | $11,957 | $269,898 | 1 |
| Anna Palucka | Clinical Mgmt Researcher | 40 | $222,540 | $0 | $23,415 | $245,955 | 1 |
| Renee Day | VP-Finance | 40 | $210,198 | $0 | $30,553 | $240,751 | 2 |
| Victoria Allgood | VP Research Operations | 40 | $103,779 | $0 | $4,321 | $108,100 | 1 |
| Zelig H Lieberman MD | Director | 1 | $0 | $19,830 | $15,609 | $35,439 | 1 |
| Louis Beecherl | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Darren Blanton | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John W Creecy | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Tiffani Evans | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert Kane Phd | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert Lavie | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Erle Nye | Director | 1 | $0 | $0 | $0 | $0 | 22 |
| R Steven Paulson MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Milla Perry Jones | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| George Race MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Jack Vaughn | Director | 1 | $0 | $0 | $0 | $0 | 1 |
2009 · 28 people listed · 15 paid, $7.7M · 307 employees · 0 volunteers
| Name | Title | Hrs/wk | From org | From related | Other | Total | Orgs |
|---|---|---|---|---|---|---|---|
| Joel Allison | Director | 1 | $0 | $1,921,774 | $353,051 | $2,274,825 | 10 |
| Paul Convery MD | Director | 1 | $0 | $813,267 | $145,052 | $958,319 | 2 |
| John McWhorter | Director | 1 | $0 | $727,393 | $136,682 | $864,075 | 17 |
| Michael Ramsay MD | President | 10 | $0 | $545,312 | $69,449 | $614,761 | 2 |
| Rowland Robinson | Director | 1 | $0 | $461,902 | $57,274 | $519,176 | 2 |
| Jacques Banchereau | Director Inst Immun Rsch | 40 | $423,446 | $0 | $56,835 | $480,281 | 1 |
| Bernard Brigonnet | Chief Operating Officer | 40 | $360,972 | $0 | $51,188 | $412,160 | 1 |
| Alan Menter MD | Medical Director | 28 | $314,496 | $0 | $431 | $314,927 | 1 |
| Shinichi Matsumoto MD PhD | Director Clin Rsch Serv | 40 | $270,175 | $0 | $27,426 | $297,601 | 1 |
| Anna Palucka | Clinical Mgmt Researcher | 40 | $233,000 | $0 | $22,167 | $255,167 | 1 |
| Maria Pascual | Clinical Mgmt Researcher | 40 | $229,181 | $0 | $11,327 | $240,508 | 1 |
| Brenda Chapman | VP Research Foundation | 40 | $172,886 | $5,388 | $19,472 | $197,746 | 2 |
| Michael Mathisen | Former Officer | 0 | $185,204 | $0 | $8,769 | $193,973 | 1 |
| Renee Day | VP-Finance | 40 | $61,630 | $0 | $12,057 | $73,687 | 2 |
| Zelig H Lieberman MD | Director | 1 | $0 | $23,251 | $12,527 | $35,778 | 1 |
| Louis Beecherl | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Darren Blanton | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| John W Creecy | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Tiffani Evans | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert Kane Phd | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Robert Lavie | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Milton Levy Jr | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Erle Nye | Director | 1 | $0 | $0 | $0 | $0 | 22 |
| R Steven Paulson MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Milla Perry Jones | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| George Race MD | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Jack Vaughn | Director | 1 | $0 | $0 | $0 | $0 | 1 |
| Victoria Allgood | VP Research Operations | 40 | $0 | $0 | $0 | $0 | 1 |
Highest-paid independent contractors
2024 · 5 contractors · $5.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor University Medical Center | Dallas, TX | Clinical Services | $1,698,461 |
| Translational Genomics Research Institut | Phoenix, AZ | Research Services | $1,312,134 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative Svcs | $1,269,777 |
| Texas Heart Hospital of the Southwest L | Dallas, TX | Clinical Services | $404,909 |
| BIR JV LLP | Dallas, TX | Clinical Services | $380,001 |
2023 · 5 contractors · $4.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor University Medical Center | Dallas, TX | Clinical Services | $1,825,921 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative Svcs | $1,461,032 |
| Baylor Institute for Rehabilitation | Dallas, TX | Clinical Services | $373,183 |
| Texas Heart Hospital of the Southwest L | Dallas, TX | Clinical Services | $311,081 |
| Scott & White Memorial Hospital | Dallas, TX | Clinical Services | $271,721 |
2022 · 5 contractors · $5.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor University Medical Center | Dallas, TX | Clinical Services | $1,517,138 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative Svcs | $1,495,591 |
| Aerotek Inc | Chicago, IL | Staffing Services | $1,219,030 |
| Texas Oncology PA | Dallas, TX | Physician Services | $865,705 |
| Polk Mechanical Company | Grand Prairie, TX | Repair Services | $817,187 |
2021 · 5 contractors · $5.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative Svcs | $1,723,396 |
| Baylor University Medical Center | Dallas, TX | Clinical Services | $1,576,837 |
| Aerotek Inc | Chicago, IL | Staffing Services | $1,248,087 |
| Norton Rose Fulbright US LLP | Dallas, TX | Legal Services | $657,101 |
| Abzena San Diego Inc | San Diego, CA | Research Services | $650,373 |
2020 · 5 contractors · $6.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor University Medical Center | Dallas, TX | Clinical Services | $2,028,304 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative Svcs | $1,832,123 |
| The Christman Company | Lansing, MI | Construction Services | $1,014,852 |
| Translational Genomics | Phoenix, AZ | Research Services | $838,202 |
| MEDCO Construction LLC | Dallas, TX | Construction Services | $469,967 |
2019 · 5 contractors · $8.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor University Medical Center | Dallas, TX | Clinical Services | $2,001,295 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative Svcs | $1,921,260 |
| Translational Genomics | Phoenix, AZ | Research Services | $1,775,848 |
| Pacificgmp | San Diego, CA | Research Services | $1,511,829 |
| MEDCO Construction LLC | Dallas, TX | Construction Services | $965,878 |
2018 · 5 contractors · $7.6M
| Name | Location | Service | Paid |
|---|---|---|---|
| Translational Genomics | Phoenix, AZ | Research Services | $2,268,931 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative Svcs | $1,723,793 |
| Baylor University Medical Center | Dallas, TX | Clinical Services | $1,672,068 |
| MEDCO Construction LLC | Dallas, TX | Construction Services | $1,098,743 |
| Norton Rose Fulbright US LLP | Dallas, TX | Legal Services | $828,567 |
2017 · 5 contractors · $6.1M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor University Medical Center | Dallas, TX | Clinical Services | $1,777,586 |
| Translational Genomics | Phoenix, AZ | Research Services | $1,535,377 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative | $1,377,176 |
| MEDCO Constructions | Dallas, TX | Construction Services | $862,425 |
| Norton Rose Fulbright US LLP | Dallas, TX | Legal Services | $571,463 |
2016 · 5 contractors · $4.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor University Medical Center | Dallas, TX | Clinical Services | $1,369,885 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative | $1,078,619 |
| Norton Rose Fulbright US LLP | Dallas, TX | Legal Services | $708,807 |
| Translational Genomics | Phoenix, AZ | Research Services | $539,518 |
| Scott & White Memorial Hospital | Temple, TX | Clinical Services | $473,560 |
2015 · 5 contractors · $2.7M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor University Medical Center | Dallas, TX | Clinical Services | $639,302 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative | $623,097 |
| Norton Rose Fulbright US LLP | Dallas, TX | Legal Fees | $518,795 |
| Cardiopulmonary Research | Dallas, TX | Professional Fees | $483,877 |
| Texas Heart Hospital of the Southwest L | Dallas, TX | Clinical Services | $451,425 |
2014 · 5 contractors · $2.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor University Medical Center | Dallas, TX | Clinical Services | $653,801 |
| Stanford University | Palo Alto, CA | Research Services | $509,429 |
| CEA Saclay | Yvette | Research Services | $436,474 |
| HealthTexas Provider Network | Dallas, TX | Clinical/Administrative | $381,032 |
| Emory University | Atlanta, GA | Research Services | $326,223 |
2013 · 5 contractors · $3.9M
| Name | Location | Service | Paid |
|---|---|---|---|
| Stanford University | Research Services | $1,114,073 | |
| Medco Construction LLC | Construction | $984,042 | |
| Baylor University Medical Center | Clinical Services | $786,501 | |
| Emory University | Research Services | $549,331 | |
| Mount Sinai School of Medicine | Research Services | $458,017 |
2012 · 5 contractors · $10.3M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor Health Care System | Dallas, TX | Management Services | $4,743,542 |
| Medco Construction LLC | Dallas, TX | Construction | $3,071,517 |
| Tulane University Medical Center | New Orleans, LA | Research Services | $1,031,420 |
| Baylor University Medical Center | Dallas, TX | Clinical Services | $923,838 |
| The Research Institute at Nationwide Chi | Columbus, OH | Research Services | $578,623 |
2011 · 5 contractors · $10.2M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor Health Care System | Dallas, TX | Management Services | $4,915,067 |
| Medco Construction LLC | Dallas, TX | Construction | $2,183,236 |
| Tulane University Medical Center | New Orleans, LA | Research Services | $1,513,440 |
| Baylor University Medical Center | Dallas, TX | Clinical Services | $935,496 |
| The Research Institute at Nationwide Chi | Columbus, OH | Research Services | $680,282 |
2010 · 5 contractors · $7.8M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor Health Care System | Dallas, TX | Management Services | $4,175,732 |
| Tulane University Medical Center | New Orleans, LA | Research Services | $1,391,990 |
| Baylor University Medical Center | Dallas, TX | Clinical Services | $1,020,175 |
| Huron Consulting Services LLC | Chicago, IL | Consulting | $625,412 |
| The Research Institute at Nationwide Chi | Columbus, OH | Research Services | $574,279 |
2009 · 5 contractors · $5.5M
| Name | Location | Service | Paid |
|---|---|---|---|
| Baylor Health Care System | Dallas, TX | Management Services | $3,459,773 |
| Baylor University Medical Center | Dallas, TX | Clinical Services | $941,125 |
| HeartPlace | Dallas, TX | Physician Services | $407,795 |
| MEDCO Construction LLC | Dallas, TX | Construction Services | $331,602 |
| Onverra Software | Richardson, TX | Consulting Services | $315,447 |
Who gave
Contributor names are not public for this form type.
Public charities filing Form 990 or 990-EZ report large donors on Schedule B, but the IRS withholds their names and addresses from public copies. Private foundations (990-PF) are different: their contributors are public.
Finances
Newest first. Each filing: its name on one row, its figures on the row beneath. Greyed filings are superseded by a later return for the same period and are left out everywhere else on this page.
| Revenue | Expenses | Assets | Net assets | Contributions | Program revenue | Officer pay | Employees | Volunteers |
|---|---|---|---|---|---|---|---|---|
| 2024 · Form 990 | ||||||||
| $89,491,341 | $85,910,172 | $191,870,643 | $172,899,033 | $42,035,733 | $33,238,900 | $1,674,482 | 594 | 0 |
| 2023 · Form 990 | ||||||||
| $84,907,337 | $78,415,673 | $171,591,125 | $157,846,516 | $43,559,993 | $31,290,840 | $1,649,461 | 572 | 0 |
| 2022 · Form 990 | ||||||||
| $73,307,762 | $76,665,102 | $157,601,006 | $145,996,311 | $36,075,918 | $25,223,172 | $1,424,913 | 570 | 0 |
| 2021 · Form 990 | ||||||||
| $70,312,625 | $68,170,124 | $163,970,510 | $152,303,796 | $39,757,092 | $20,819,455 | $936,675 | 534 | 0 |
| 2020 · Form 990 | ||||||||
| $77,117,798 | $65,145,979 | $167,191,620 | $156,856,910 | $36,056,264 | $32,559,788 | $895,697 | 519 | 0 |
| 2019 · Form 990 | ||||||||
| $71,333,023 | $66,124,848 | $139,937,615 | $130,252,019 | $35,615,550 | $29,000,317 | $1,010,096 | 623 | 0 |
| 2018 · Form 990 | ||||||||
| $69,331,263 | $69,230,447 | $165,250,659 | $150,062,185 | $44,547,066 | $23,281,627 | $1,118,986 | 620 | 4 |
| 2017 · Form 990 | ||||||||
| $74,456,233 | $70,238,304 | $149,737,447 | $126,571,299 | $49,203,979 | $21,936,276 | $1,072,725 | 703 | 4 |
| 2016 · Form 990 | ||||||||
| $67,527,910 | $67,109,598 | $136,825,951 | $109,687,177 | $43,094,084 | $20,496,815 | $1,080,469 | 494 | 4 |
| 2015 · Form 990 | ||||||||
| $61,713,937 | $61,826,347 | $135,691,222 | $108,291,000 | $39,229,580 | $19,661,135 | $1,038,338 | 492 | 3 |
| 2014 · Form 990 | ||||||||
| $61,768,964 | $63,008,893 | $138,238,739 | $110,038,268 | $40,516,275 | $18,089,192 | $1,009,201 | 459 | 3 |
| 2013 · Form 990 | ||||||||
| $68,465,974 | $61,860,765 | $148,560,662 | $110,436,908 | $64,944,746 | $4,761,464 | $1,038,813 | 447 | 9 |
| 2012 · Form 990 | ||||||||
| $56,390,365 | $62,159,368 | $151,818,242 | $99,800,353 | $46,975,848 | $4,339,804 | $1,296,220 | 414 | 0 |
| 2011 · Form 990 | ||||||||
| $57,804,654 | $55,949,126 | $135,886,713 | $101,072,992 | $49,538,025 | $3,294,638 | $1,531,231 | 346 | 0 |
| 2010 · Form 990 | ||||||||
| $51,740,018 | $53,563,247 | $118,062,719 | $87,758,702 | $51,515,842 | $4,099,548 | $1,001,233 | 333 | 0 |
| 2009 · Form 990 | ||||||||
| $46,375,402 | $46,418,959 | $103,232,792 | $78,630,348 | $38,038,015 | $5,116,936 | $803,630 | 307 | 0 |
Connected to
Organizations that list some of the same people on their returns (officers, directors, key employees on this organization’s latest return), and related organizations it lists on Schedule R.
- SCOTT & WHITE MEMORIAL HOSPITAL Dallas, TX · 2 people in common (Alejandro Arroliga MD, Suzy Gulliver)
- BAYLOR SCOTT & WHITE HEALTH Dallas, TX · 2 people in common (Alejandro Arroliga MD, Steven Newton)
- SCOTT & WHITE HEALTHCARE FOUNDATION Dallas, TX · 2 people in common (Alejandro Arroliga MD, Amy Martin)
- BAYLOR SCOTT & WHITE HOLDINGS Dallas, TX · 2 people in common (Alejandro Arroliga MD, Steven Newton)
- ALL SAINTS HEALTH FOUNDATION Dallas, TX · 2 people in common (Amy Martin, Steven Newton) · related organization (Schedule R)
- BAYLOR UNIVERSITY MEDICAL CENTER Dallas, TX · 1 person in common (Steven Newton)
- HEALTHTEXAS PROVIDER NETWORK Dallas, TX · 1 person in common (Michael J Mack MD)
- SCOTT & WHITE CLINIC Dallas, TX · 1 person in common (Alejandro Arroliga MD) · related organization (Schedule R)
- BAYLOR ALL SAINTS MEDICAL CENTER Dallas, TX · 1 person in common (Steven Newton)
- SCOTT & WHITE HOSPITAL ROUND ROCK Dallas, TX · 1 person in common (Alejandro Arroliga MD)
- BAYLOR REGIONAL MEDICAL CENTER AT GRAPEVINE Dallas, TX · 1 person in common (Steven Newton)
- CENTURY INTEGRATED PARTNERS INC Dallas, TX · 1 person in common (Alejandro Arroliga MD) · related organization (Schedule R)
- SCOTT & WHITE HOSPITAL Dallas, TX · 1 person in common (Alejandro Arroliga MD)
- BAYLOR HEALTH CARE SYSTEM FOUNDATION Dallas, TX · 1 person in common (Amy Martin)
- SCOTT & WHITE HOSPITAL-TAYLOR Dallas, TX · 1 person in common (Alejandro Arroliga MD) · related organization (Schedule R)
- SCOTT & WHITE CONTINUING CARE HOSPITAL Dallas, TX · 1 person in common (Alejandro Arroliga MD)
- Baylor Institute for Rehabilitation Dallas, TX · 1 person in common (Steven Newton)
- IRVING HEALTHCARE FOUNDATION Irving, TX · 1 person in common (Amy Martin)
- SCOTT & WHITE FOUNDATION BRENHAM Dallas, TX · 1 person in common (Amy Martin) · related organization (Schedule R)
- BELL COUNTY HEALTHCARE COLLABORATIVE Dallas, TX · 1 person in common (Alejandro Arroliga MD)
Funders of this organization
54 grantors reported grants to this organization, $440,453,263 in all, tax years 2009 to 2024; the 25 largest shown (all 54). Exact: the grantor wrote this organization's EIN. Fuzzy: the grantor wrote only a name (foundations' 990-PF has no EIN field), matched to the same or a near-identical name in the same state; the name as filed is shown. From the latest return for each grantor and year, so amended returns aren't counted twice. CSV
| Grantor | Type | Match | Years given | Grants | Total | Latest year | Latest year's amount | Grants |
|---|---|---|---|---|---|---|---|---|
| BAYLOR UNIVERSITY MEDICAL CENTER | Public charity | Exact | 2009-2024 | 16 | $241,595,138 | 2024 | $11,486,828 | show |
| BAYLOR HEALTH CARE SYSTEM FOUNDATION | Public charity | Exact | 2009-2024 | 16 | $149,664,137 | 2024 | $10,380,334 | show |
| SCOTT & WHITE HEALTHCARE FOUNDATION | Public charity | Exact | 2017-2024 | 8 | $10,548,564 | 2024 | $1,966,534 | show |
| SCOTT & WHITE MEMORIAL HOSPITAL | Public charity | Exact | 2018-2024 | 7 | $8,889,194 | 2024 | $1,076,635 | show |
| CRITICAL PATH INSTITUTE | Public charity | Exact | 2014-2019 | 6 | $6,360,629 | 2019 | $995,538 | show |
| BREAKTHROUGH T1D | Public charity | Exact | 2009-2010, 2012, 2014-2018, 2020, 2024 | 10 | $3,395,368 | 2024 | $249,939 | show |
| BAYLOR ALL SAINTS MEDICAL CENTER | Public charity | Exact | 2009-2010, 2015-2024 | 12 | $3,106,285 | 2024 | $111,057 | show |
| GEORGE WASHINGTON UNIVERSITY | Public charity | Exact | 2012-2021, 2023 | 11 | $2,951,282 | 2023 | $20,282 | show |
| VANDERBILT UNIVERSITY MEDICAL CENTER | Public charity | Exact | 2021-2024 | 4 | $2,791,556 | 2024 | $954,756 | show |
| BAYLOR REGIONAL MEDICAL CENTER AT PLANO | Public charity | Exact | 2012-2024 | 13 | $2,473,998 | 2024 | $120,271 | show |
| MAYO CLINIC | DAF sponsor | Exact | 2010-2017, 2022-2023 | 10 | $1,647,439 | 2023 | $10,883 | show |
| CROHNS & COLITIS FOUNDATION INC | Public charity | Exact | 2018-2020, 2023-2024 | 5 | $592,064 | 2024 | $269,345 | show |
| LUPUS RESEARCH ALLIANCE INC | Public charity | Exact | 2011-2013, 2016 | 4 | $560,454 | 2016 | $50,000 | show |
| BAYLOR UNIVERSITY | DAF sponsor | Exact | 2020-2024 | 6 | $550,992 | 2024 | $20,808 | show |
| NATIONAL PSORIASIS FOUNDATION | Public charity | Exact | 2011-2015 | 7 | $505,000 | 2015 | $50,000 | show |
| ALLIANCE FOR CLINICAL TRIALS IN ONCOLOGY FOUNDATION | Public charity | Exact | 2020-2024 | 5 | $501,890 | 2024 | $147,607 | show |
| REHABILITATION INSTITUTE OF CHICAGO | Public charity | Exact | 2023-2024 | 2 | $362,556 | 2024 | $341,308 | show |
| RENSSELAER POLYTECHNIC INSTITUTE | Public charity | Exact | 2018-2020 | 3 | $306,902 | 2020 | $60,652 | show |
| VANDERBILT UNIVERSITY | Public charity | Exact | 2011-2015 | 5 | $302,336 | 2015 | $61,931 | show |
| UNIVERSITY OF PITTSBURGH | Public charity | Exact | 2012-2014, 2021 | 4 | $278,618 | 2021 | $16,821 | show |
| KAISER FOUNDATION HOSPITALS | Public charity | Exact | 2019-2023 | 5 | $251,940 | 2023 | $17,084 | show |
| KAISER FOUNDATION HEALTH PLAN OF WASHINGTON | Public charity | Exact | 2020-2024 | 5 | $250,775 | 2024 | $40,145 | show |
| MONTEFIORE MEDICAL CENTER | Public charity | Exact | 2010-2012 | 3 | $235,146 | 2012 | $32,827 | show |
| LUPUS RESEARCH INSTITUTE INC | Public charity | Exact | 2014 | 1 | $200,000 | 2014 | $200,000 | show |
| THE MULTIPLE MYELOMA RESEARCH FOUNDATION INC | Public charity | Exact | 2015-2019 | 5 | $185,000 | 2019 | $25,000 | show |
Nearby + Similar BETA
Organizations like this one: what they do and who they are linked to
Same category: NTEE code and revenue
Ranked without any AI: same NTEE code first, then the same NTEE group; then revenue within 2x, 5x or 10x; then the same state; then similar name and mission text. Same state only · More (100)
| Organization | State | NTEE | Latest revenue | Latest expenses | Top-paid title | Top pay | Why similar |
|---|---|---|---|---|---|---|---|
| HENNEPIN HEALTHCARE RESEARCH INSTITUTE | MN | H90 | $54,717,221 | $53,504,403 | DIRECTOR/PHYSICIAN (UNTIL 6/24) | $660,695 | Same NTEE code H90, revenue within 2x, similar mission |
| THE FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH | NY | H90 | $163,308,471 | $163,279,325 | EVP & CFO | $1,990,193 | Same NTEE code H90, revenue within 2x, similar name |
| TRANSLATIONAL GENOMICS RESEARCH INSTITUTE | AZ | H90 | $75,913,310 | $86,279,860 | BD & VICE CHRM/COH CEO & PRES. | $7,115,857 | Same NTEE code H90, revenue within 2x |
| LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL | CA | H90 | $94,550,669 | $106,850,446 | INTERIM CEO | $925,655 | Same NTEE code H90, revenue within 2x |
| J DAVID GLADSTONE INSTITUTES | CA | H90 | $119,155,911 | $144,808,821 | PRESIDENT | $1,182,258 | Same NTEE code H90, revenue within 2x |
| THE MEDICAL UNIVERSITY OF SOUTH CAROLINA FOUNDATION | SC | H90 | $136,664,063 | $81,004,152 | CHIEF EXECUTIVE OFFICER | $635,452 | Same NTEE code H90, revenue within 2x |
| SPORTS MEDICINE RESEARCH AND TESTING LABORATORY | UT | H90 | $24,588,184 | $16,194,140 | PRESIDENT/LAB DIRECTOR | $622,114 | Same NTEE code H90, revenue within 5x |
| MONELL CHEMICAL SENSES CENTER | PA | H90 | $20,726,758 | $20,366,058 | Exec Dir President | $360,927 | Same NTEE code H90, revenue within 5x |
| WILLIAM K WARREN MEDICAL RESEARCH CENTER INC | OK | H90 | $16,183,718 | $1,805,546 | DIRECTOR | $508,503 | Same NTEE code H90, revenue within 10x |
| ESSENTIA INSTITUTE OF RURAL HEALTH | MN | H90 | $10,547,026 | $12,202,333 | BOARD CHAIR/RELATED ORG PHYSICIAN | $932,372 | Same NTEE code H90, revenue within 10x |
| VETERANS MEDICAL RESEARCH FOUNDATION OF SD | CA | H90 | $16,030,812 | $16,560,898 | EXECUTIVE DIRECTOR/CEO | $405,278 | Same NTEE code H90, revenue within 10x |
| REGENSTRIEF FOUNDATION INC | IN | H90 | $14,893,999 | $11,220,711 | PRESIDENT & DIRECTOR | $221,759 | Same NTEE code H90, revenue within 10x |
| RESEARCH UPDATE | TX | H90 | $686,545 | $596,683 | PRESIDENT/CEO | $100,000 | Same NTEE code H90, revenue differs more than 10x, same state |
| FOUNDATION FOR ADVANCING VETERANS HEALTH RESEARCH INC | TX | H90 | $6,279,758 | $7,592,277 | DIRECTOR | $379,655 | Same NTEE code H90, revenue differs more than 10x, same state |
| CENTRAL TEXAS VETERANS RESEARCH FOUNDATION | TX | H90 | $1,811,673 | $1,649,268 | BOARD MEMBER | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| UROLOGY RESEARCH AND EDUCATION FOUNDATION | TX | H90 | $38,637 | $36,701 | DIRECTOR | $22,833 | Same NTEE code H90, revenue differs more than 10x, same state |
| AMERICAN HAND THERAPY FOUNDATION INC | TX | H90 | $144,325 | $132,693 | CHAIR | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| ATHLETIC AND ORTHOPEDIC RESEARCH FOUNDATION | TX | H90 | $36,050 | $50,289 | PRESIDENT | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| FOUNDATION FOR ADVANCES IN THERAPEU TICS AND PREVENTION | TX | H90 | $93,497 | $425 | PRESIDENT | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| CAN DO HOUSTON | TX | H90 | $255,316 | $452,949 | EXECUTIVE DI | $59,750 | Same NTEE code H90, revenue differs more than 10x, same state |
| BUDOFF UPPER EXTREMITY RESEARCH FOUNDATION | TX | H90 | $9,311 | $23,465 | PRESIDENT | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| COMMON SENSE MEDICINE INC | TX | H90 | $278,662 | $119,855 | PRESIDENT | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| SCIENCE UNBOUND FOUNDATION INC | TX | H90 | $50,446 | $21,375 | PRESIDENT | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| HATCHING FOR HEALTH FOUNDATION | TX | H90 | $71,309 | $85,871 | DIRECTOR | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
| NORTH AMERICAN ARTERY | TX | H90 | $93,847 | $65,929 | SECRETARY | $0 | Same NTEE code H90, revenue differs more than 10x, same state |
Who funds organizations like this
Grantors that funded the 100 most similar organizations. Ranked by total given to them. Foundations (990-PF) and donor-advised fund sponsors only. Same matching as Funders above (by EIN, or by name for foundations).
The full list · all similar organizations
Where the money went
Every expense line on each return, biggest first: Form 990 Part IX (with its program, management and fundraising columns), 990-EZ Part I, or 990-PF Part I. Event marks lines the organization itself describes as events. “Events” in each summary adds those lines, conferences and meetings, and the direct costs of fundraising events. Unusual is not the same as improper. Many of these patterns have ordinary explanations. Check the filing.
2024 · Form 990 · $85,910,172 spent · pay $55,678,294 · grants $0 · events $287,224
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $45,208,816 | $41,627,888 | $3,580,928 | - | 52.6% | |
| Fees: other services | $12,621,486 | $9,042,911 | $3,578,575 | - | 14.7% | |
| Royalties | $4,511,158 | $4,511,158 | - | - | 5.3% | |
| Information technology | $4,449,913 | $4,086,850 | $363,063 | - | 5.2% | |
| Other employee benefits | $4,092,392 | $3,768,239 | $324,153 | - | 4.8% | |
| Occupancy | $3,324,866 | $3,286,377 | $38,489 | - | 3.9% | |
| Payroll taxes | $3,039,250 | $2,806,632 | $232,618 | - | 3.5% | |
| Depreciation and depletion | $1,761,714 | $1,761,714 | - | - | 2.1% | |
| Pay: officers, directors, trustees, key employees | $1,674,482 | - | $1,674,482 | - | 1.9% | |
| Pension plan contributions | $1,562,889 | $1,439,095 | $123,794 | - | 1.8% | |
| Other (as described) | Medical Supplies | $1,435,760 | $1,435,760 | - | - | 1.7% |
| Travel | $512,441 | $463,576 | $48,865 | - | 0.6% | |
| Other (as described) | Non Medical Supplies | $469,228 | $464,467 | $4,761 | - | 0.5% |
| Conferences, conventions and meetings | $287,224 | $143,058 | $144,166 | - | 0.3% | |
| Office expenses | $263,489 | $227,880 | $35,609 | - | 0.3% | |
| All other expenses | $188,713 | $172,821 | $15,892 | - | 0.2% | |
| Advertising and promotion | $132,532 | $104,428 | $28,104 | - | 0.2% | |
| Fees: legal | $108,119 | - | $108,119 | - | 0.1% | |
| Pay: disqualified persons | $100,465 | $100,465 | - | - | 0.1% | |
| Other (as described) | Dues and Memberships | $90,717 | $81,944 | $8,773 | - | 0.1% |
| Other (as described) | Meals and Entertainment | $39,848 | $37,147 | $2,701 | - | 0.0% |
| Insurance | $29,281 | - | $29,281 | - | 0.0% | |
| Fees: lobbying | $5,389 | - | $5,389 | - | 0.0% | |
| Total | $85,910,172 | 100% |
2023 · Form 990 · $78,415,673 spent · pay $50,110,512 · grants $0 · events $315,046
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $39,823,040 | $37,495,590 | $2,327,450 | - | 50.8% | |
| Fees: other services | $12,001,640 | $8,716,583 | $3,285,057 | - | 15.3% | |
| Other employee benefits | $4,321,067 | $3,624,506 | $696,561 | - | 5.5% | |
| Information technology | $4,144,068 | $3,778,598 | $365,470 | - | 5.3% | |
| Royalties | $3,896,362 | $3,896,362 | - | - | 5.0% | |
| Occupancy | $3,400,275 | $3,377,880 | $22,395 | - | 4.3% | |
| Payroll taxes | $2,789,433 | $2,356,215 | $433,218 | - | 3.6% | |
| Depreciation and depletion | $1,746,590 | $1,746,590 | - | - | 2.2% | |
| Pay: officers, directors, trustees, key employees | $1,649,461 | - | $1,649,461 | - | 2.1% | |
| Pension plan contributions | $1,446,679 | $1,213,473 | $233,206 | - | 1.8% | |
| Other (as described) | Medical Supplies | $1,232,969 | $1,232,969 | - | - | 1.6% |
| Travel | $403,867 | $378,124 | $25,743 | - | 0.5% | |
| Other (as described) | Non Medical Supplies | $388,606 | $384,356 | $4,250 | - | 0.5% |
| Conferences, conventions and meetings | $315,046 | $193,423 | $121,623 | - | 0.4% | |
| Office expenses | $253,864 | $227,687 | $26,177 | - | 0.3% | |
| All other expenses | $212,894 | $201,825 | $11,069 | - | 0.3% | |
| Fees: legal | $99,917 | - | $99,917 | - | 0.1% | |
| Advertising and promotion | $91,235 | $75,784 | $15,451 | - | 0.1% | |
| Pay: disqualified persons | $80,832 | $80,832 | - | - | 0.1% | |
| Other (as described) | Dues and Memberships | $47,478 | $36,598 | $10,880 | - | 0.1% |
| Other (as described) | Meals and Entertainment | $36,942 | $35,347 | $1,595 | - | 0.0% |
| Insurance | $29,364 | - | $29,364 | - | 0.0% | |
| Fees: lobbying | $4,044 | - | $4,044 | - | 0.0% | |
| Total | $78,415,673 | 100% |
2022 · Form 990 · $76,665,102 spent · pay $46,771,628 · grants $0 · events $156,644
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $37,239,378 | $34,293,734 | $2,945,644 | - | 48.6% | |
| Fees: other services | $16,788,675 | $14,179,771 | $2,608,904 | - | 21.9% | |
| Other employee benefits | $4,265,640 | $3,927,575 | $338,065 | - | 5.6% | |
| Information technology | $3,626,754 | $3,240,613 | $386,141 | - | 4.7% | |
| Occupancy | $2,917,477 | $2,899,413 | $18,064 | - | 3.8% | |
| Payroll taxes | $2,504,550 | $2,312,563 | $191,987 | - | 3.3% | |
| Other (as described) | Medical Supplies | $2,218,835 | $2,218,835 | - | - | 2.9% |
| Depreciation and depletion | $2,159,715 | $2,159,715 | - | - | 2.8% | |
| Pay: officers, directors, trustees, key employees | $1,424,913 | - | $1,424,913 | - | 1.9% | |
| Pension plan contributions | $1,301,503 | $1,198,355 | $103,148 | - | 1.7% | |
| Other (as described) | Non-Medical Supplies | $521,550 | $508,231 | $13,319 | - | 0.7% |
| Office expenses | $376,520 | $348,576 | $27,944 | - | 0.5% | |
| Travel | $351,884 | $325,513 | $26,371 | - | 0.5% | |
| All other expenses | $294,081 | $275,053 | $19,028 | - | 0.4% | |
| Other (as described) | Bad Debt | $199,013 | $199,013 | - | - | 0.3% |
| Conferences, conventions and meetings | $156,644 | $132,495 | $24,149 | - | 0.2% | |
| Other (as described) | Dues and Memberships | $127,424 | $95,100 | $32,324 | - | 0.2% |
| Advertising and promotion | $84,902 | $76,957 | $7,945 | - | 0.1% | |
| Fees: legal | $41,350 | - | $41,350 | - | 0.1% | |
| Pay: disqualified persons | $35,644 | $35,644 | - | - | 0.0% | |
| Insurance | $24,684 | - | $24,684 | - | 0.0% | |
| Fees: lobbying | $3,966 | - | $3,966 | - | 0.0% | |
| Total | $76,665,102 | 100% |
2021 · Form 990 · $68,170,124 spent · pay $39,734,964 · grants $0 · events $130,351
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $31,928,498 | $29,584,803 | $2,343,695 | - | 46.8% | |
| Fees: other services | $15,957,367 | $14,094,387 | $1,862,980 | - | 23.4% | |
| Other employee benefits | $3,570,494 | $3,308,235 | $262,259 | - | 5.2% | |
| Information technology | $3,487,445 | $3,194,051 | $293,394 | - | 5.1% | |
| Occupancy | $2,731,543 | $2,678,085 | $53,458 | - | 4.0% | |
| Depreciation and depletion | $2,357,970 | $2,357,970 | - | - | 3.5% | |
| Other (as described) | Medical Supplies | $2,285,871 | $2,285,871 | - | - | 3.4% |
| Payroll taxes | $2,146,907 | $1,993,161 | $153,746 | - | 3.1% | |
| Pension plan contributions | $1,152,390 | $1,067,783 | $84,607 | - | 1.7% | |
| Pay: officers, directors, trustees, key employees | $936,675 | - | $936,675 | - | 1.4% | |
| Other (as described) | Non-Medical Supplies | $475,822 | $462,371 | $13,451 | - | 0.7% |
| Office expenses | $335,962 | $247,656 | $88,306 | - | 0.5% | |
| Advertising and promotion | $272,992 | $131,081 | $141,911 | - | 0.4% | |
| Travel | $140,360 | $123,908 | $16,452 | - | 0.2% | |
| Conferences, conventions and meetings | $130,351 | $106,551 | $23,800 | - | 0.2% | |
| Other (as described) | Dues & Memberships | $95,952 | $63,319 | $32,633 | - | 0.1% |
| All other expenses | $78,725 | $59,387 | $19,338 | - | 0.1% | |
| Insurance | $29,972 | - | $29,972 | - | 0.0% | |
| Other (as described) | Recruiting | $28,276 | $28,276 | - | - | 0.0% |
| Fees: legal | $24,563 | - | $24,563 | - | 0.0% | |
| Fees: lobbying | $1,989 | - | $1,989 | - | 0.0% | |
| Total | $68,170,124 | 100% |
2020 · Form 990 · $65,145,979 spent · pay $36,878,470 · grants $0 · events $185,955
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $29,444,354 | $27,633,886 | $1,810,468 | - | 45.2% | |
| Fees: other services | $18,231,904 | $13,724,900 | $4,507,004 | - | 28.0% | |
| Other employee benefits | $3,418,692 | $3,207,954 | $210,738 | - | 5.2% | |
| Information technology | $2,488,433 | $2,478,713 | $9,720 | - | 3.8% | |
| Depreciation and depletion | $2,463,103 | $2,463,103 | - | - | 3.8% | |
| Occupancy | $2,370,400 | $2,230,579 | $139,821 | - | 3.6% | |
| Payroll taxes | $2,090,090 | $1,964,444 | $125,646 | - | 3.2% | |
| Other (as described) | Medical Supplies | $1,402,970 | $1,402,970 | - | - | 2.2% |
| Pension plan contributions | $1,029,637 | $966,090 | $63,547 | - | 1.6% | |
| Pay: officers, directors, trustees, key employees | $895,697 | - | $895,697 | - | 1.4% | |
| Office expenses | $389,832 | $282,610 | $107,222 | - | 0.6% | |
| Advertising and promotion | $225,399 | $37,005 | $188,394 | - | 0.3% | |
| Conferences, conventions and meetings | $185,955 | $65,685 | $120,270 | - | 0.3% | |
| Other (as described) | Non-Medical Supplies | $160,440 | $153,093 | $7,347 | - | 0.2% |
| All other expenses | $135,509 | $92,920 | $42,589 | - | 0.2% | |
| Other (as described) | Patent Reserve | $101,836 | $101,836 | - | - | 0.2% |
| Travel | $64,022 | $60,663 | $3,359 | - | 0.1% | |
| Fees: legal | $15,404 | - | $15,404 | - | 0.0% | |
| Insurance | $15,208 | - | $15,208 | - | 0.0% | |
| Other (as described) | Federal Income Tax | $12,982 | - | $12,982 | - | 0.0% |
| Fees: lobbying | $4,112 | - | $4,112 | - | 0.0% | |
| Total | $65,145,979 | 100% |
2019 · Form 990 · $66,124,848 spent · pay $35,916,599 · grants $0 · events $303,420
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $29,142,303 | $26,456,859 | $2,685,444 | - | 44.1% | |
| Fees: other services | $17,941,268 | $13,597,763 | $4,343,505 | - | 27.1% | |
| Depreciation and depletion | $2,874,356 | $2,874,356 | - | - | 4.3% | |
| Occupancy | $2,844,157 | $2,746,821 | $97,336 | - | 4.3% | |
| Information technology | $2,810,419 | $2,802,403 | $8,016 | - | 4.3% | |
| Other employee benefits | $2,758,147 | $2,408,398 | $349,749 | - | 4.2% | |
| Payroll taxes | $1,975,728 | $1,799,026 | $176,702 | - | 3.0% | |
| Other (as described) | Medical Supplies | $1,504,002 | $1,504,002 | - | - | 2.3% |
| Pay: officers, directors, trustees, key employees | $1,010,096 | - | $1,010,096 | - | 1.5% | |
| Pension plan contributions | $942,623 | $855,615 | $87,008 | - | 1.4% | |
| Other (as described) | Patent Reserve | $547,205 | $547,205 | - | - | 0.8% |
| Other (as described) | Non-Medical Supplies | $434,172 | $418,893 | $15,279 | - | 0.7% |
| Travel | $344,036 | $252,859 | $91,177 | - | 0.5% | |
| Conferences, conventions and meetings | $303,420 | $93,070 | $210,350 | - | 0.5% | |
| Office expenses | $290,220 | $247,392 | $42,828 | - | 0.4% | |
| All other expenses | $253,121 | $179,606 | $73,515 | - | 0.4% | |
| Pay: disqualified persons | $87,702 | $87,702 | - | - | 0.1% | |
| Advertising and promotion | $59,254 | $33,835 | $25,419 | - | 0.1% | |
| Fees: legal | $10,035 | - | $10,035 | - | 0.0% | |
| Insurance | $8,852 | - | $8,852 | - | 0.0% | |
| Fees: lobbying | $3,133 | - | $3,133 | - | 0.0% | |
| Other (as described) | Federal Income Tax | -$19,401 | -$19,401 | - | - | -0.0% |
| Total | $66,124,848 | 100% |
2018 · Form 990 · $69,230,447 spent · pay $35,743,966 · grants $0 · events $270,341
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $29,031,763 | $25,937,371 | $3,094,392 | - | 41.9% | |
| Fees: other services | $17,889,841 | $14,738,206 | $3,151,635 | - | 25.8% | |
| Occupancy | $4,271,180 | $4,151,100 | $120,080 | - | 6.2% | |
| Depreciation and depletion | $3,518,201 | $3,518,201 | - | - | 5.1% | |
| Other employee benefits | $2,776,691 | $2,479,939 | $296,752 | - | 4.0% | |
| Other (as described) | Medical Supplies | $2,699,254 | $2,699,254 | - | - | 3.9% |
| Information technology | $2,112,485 | $2,016,806 | $95,679 | - | 3.1% | |
| Payroll taxes | $1,843,688 | $1,653,692 | $189,996 | - | 2.7% | |
| Pay: officers, directors, trustees, key employees | $1,118,986 | - | $1,118,986 | - | 1.6% | |
| Pension plan contributions | $888,558 | $793,560 | $94,998 | - | 1.3% | |
| Advertising and promotion | $667,529 | $495,586 | $171,943 | - | 1.0% | |
| Travel | $475,821 | $327,244 | $148,577 | - | 0.7% | |
| Other (as described) | Patent Reserve | $453,894 | $453,894 | - | - | 0.7% |
| Office expenses | $448,937 | $436,689 | $12,248 | - | 0.6% | |
| All other expenses | $357,950 | $233,662 | $124,288 | - | 0.5% | |
| Other (as described) | Non-Medical Supplies | $292,393 | $238,320 | $54,073 | - | 0.4% |
| Conferences, conventions and meetings | $270,341 | $138,534 | $131,807 | - | 0.4% | |
| Pay: disqualified persons | $84,280 | $84,280 | - | - | 0.1% | |
| Insurance | $11,070 | - | $11,070 | - | 0.0% | |
| Fees: lobbying | $10,340 | - | $10,340 | - | 0.0% | |
| Other (as described) | Federal Income Tax | $6,069 | - | $6,069 | - | 0.0% |
| Fees: legal | $1,176 | - | $1,176 | - | 0.0% | |
| Total | $69,230,447 | 100% |
2017 · Form 990 · $70,238,304 spent · pay $35,008,796 · grants $0 · events $144,099
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $27,998,513 | $24,850,182 | $3,148,331 | - | 39.9% | |
| Fees: other services | $18,281,051 | $13,657,721 | $4,623,330 | - | 26.0% | |
| Occupancy | $4,484,559 | $3,571,981 | $912,578 | - | 6.4% | |
| Other (as described) | Medical Supplies | $4,073,329 | $4,073,329 | - | - | 5.8% |
| Depreciation and depletion | $3,697,761 | $3,697,761 | - | - | 5.3% | |
| Other employee benefits | $3,054,322 | $2,709,895 | $344,427 | - | 4.3% | |
| Information technology | $2,088,665 | $1,998,571 | $90,094 | - | 3.0% | |
| Payroll taxes | $1,859,178 | $1,656,740 | $202,438 | - | 2.6% | |
| Pay: officers, directors, trustees, key employees | $1,072,725 | - | $1,072,725 | - | 1.5% | |
| Pension plan contributions | $940,470 | $834,371 | $106,099 | - | 1.3% | |
| Office expenses | $573,561 | $494,098 | $79,463 | - | 0.8% | |
| Travel | $432,015 | $288,455 | $143,560 | - | 0.6% | |
| Fees: legal | $392,374 | - | $392,374 | - | 0.6% | |
| Other (as described) | Patent Reserve | $328,319 | $328,319 | - | - | 0.5% |
| All other expenses | $318,376 | $160,982 | $157,394 | - | 0.5% | |
| Other (as described) | Non-Medical Supplies | $225,746 | $168,388 | $57,358 | - | 0.3% |
| Advertising and promotion | $158,783 | $79,643 | $79,140 | - | 0.2% | |
| Conferences, conventions and meetings | $144,099 | $81,204 | $62,895 | - | 0.2% | |
| Pay: disqualified persons | $83,588 | $83,588 | - | - | 0.1% | |
| Insurance | $22,042 | - | $22,042 | - | 0.0% | |
| Fees: lobbying | $8,794 | - | $8,794 | - | 0.0% | |
| Other (as described) | Federal Income Tax | $34 | - | $34 | - | 0.0% |
| Total | $70,238,304 | 100% |
2016 · Form 990 · $67,109,598 spent · pay $34,218,400 · grants $0 · events $200,956
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $27,467,585 | $22,725,199 | $4,742,386 | - | 40.9% | |
| Fees: other services | $17,132,679 | $11,381,792 | $5,750,887 | - | 25.5% | |
| Occupancy | $4,082,704 | $3,264,052 | $818,652 | - | 6.1% | |
| Depreciation and depletion | $3,880,867 | $3,880,867 | - | - | 5.8% | |
| Other (as described) | Medical Supplies | $3,795,520 | $3,795,520 | - | - | 5.7% |
| Other employee benefits | $2,877,830 | $2,379,405 | $498,425 | - | 4.3% | |
| Payroll taxes | $1,800,610 | $1,443,218 | $357,392 | - | 2.7% | |
| Information technology | $1,467,594 | $1,441,518 | $26,076 | - | 2.2% | |
| Pay: officers, directors, trustees, key employees | $1,080,469 | - | $1,080,469 | - | 1.6% | |
| Pension plan contributions | $951,117 | $804,951 | $146,166 | - | 1.4% | |
| Office expenses | $566,698 | $513,228 | $53,470 | - | 0.8% | |
| Travel | $564,147 | $433,473 | $130,674 | - | 0.8% | |
| All other expenses | $472,936 | $285,720 | $187,216 | - | 0.7% | |
| Other (as described) | Patent Reserve | $345,200 | $345,200 | - | - | 0.5% |
| Other (as described) | Non-Medical Supplies | $276,974 | $240,039 | $36,935 | - | 0.4% |
| Conferences, conventions and meetings | $200,956 | $94,899 | $106,057 | - | 0.3% | |
| Advertising and promotion | $82,913 | $48,021 | $34,892 | - | 0.1% | |
| Pay: disqualified persons | $40,789 | $40,789 | - | - | 0.1% | |
| Fees: lobbying | $13,622 | - | $13,622 | - | 0.0% | |
| Insurance | $7,903 | - | $7,903 | - | 0.0% | |
| Other (as described) | Federal Income Tax | $485 | - | $485 | - | 0.0% |
| Total | $67,109,598 | 100% |
2015 · Form 990 · $61,826,347 spent · pay $33,182,153 · grants $0 · events $273,950
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $26,253,769 | $22,187,789 | $4,065,980 | - | 42.5% | |
| Fees: other services | $13,283,402 | $8,392,840 | $4,890,562 | - | 21.5% | |
| Occupancy | $3,963,291 | $3,448,029 | $515,262 | - | 6.4% | |
| Depreciation and depletion | $3,939,400 | $3,939,400 | - | - | 6.4% | |
| Other (as described) | Medical Supplies | $3,411,846 | $3,411,846 | - | - | 5.5% |
| Other employee benefits | $3,309,570 | $2,777,399 | $532,171 | - | 5.4% | |
| Payroll taxes | $1,744,069 | $1,463,064 | $281,005 | - | 2.8% | |
| Information technology | $1,242,435 | $1,242,435 | - | - | 2.0% | |
| Pay: officers, directors, trustees, key employees | $1,038,338 | - | $1,038,338 | - | 1.7% | |
| Pension plan contributions | $836,407 | $722,541 | $113,866 | - | 1.4% | |
| Other (as described) | Patent Reserve | $621,999 | $621,999 | - | - | 1.0% |
| Office expenses | $535,048 | $446,212 | $88,836 | - | 0.9% | |
| Travel | $525,435 | $406,982 | $118,453 | - | 0.8% | |
| Other (as described) | Non-Medical Supplies | $381,747 | $326,873 | $54,874 | - | 0.6% |
| All other expenses | $294,657 | $222,078 | $72,579 | - | 0.5% | |
| Conferences, conventions and meetings | $273,950 | $94,063 | $179,887 | - | 0.4% | |
| Other (as described) | Meals & Entertainment | $63,615 | $39,708 | $23,907 | - | 0.1% |
| Advertising and promotion | $49,520 | $30,965 | $18,555 | - | 0.1% | |
| Insurance | $44,597 | - | $44,597 | - | 0.1% | |
| Fees: lobbying | $10,587 | - | $10,587 | - | 0.0% | |
| Fees: legal | $2,665 | - | $2,665 | - | 0.0% | |
| Total | $61,826,347 | 100% |
2014 · Form 990 · $63,008,893 spent · pay $30,222,801 · grants $0 · events $161,285
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $24,055,144 | $21,125,469 | $2,929,675 | - | 38.2% | |
| Fees: other services | $12,556,199 | $7,984,802 | $4,571,397 | - | 19.9% | |
| Other (as described) | Patent Reserve | $4,955,731 | $4,955,731 | - | - | 7.9% |
| Depreciation and depletion | $4,076,699 | $4,076,699 | - | - | 6.5% | |
| Other (as described) | Medical Supplies | $4,040,459 | $4,040,459 | - | - | 6.4% |
| Occupancy | $3,801,504 | $3,441,734 | $359,770 | - | 6.0% | |
| Other employee benefits | $2,701,947 | $2,401,385 | $300,562 | - | 4.3% | |
| Payroll taxes | $1,704,400 | $1,402,871 | $301,529 | - | 2.7% | |
| Information technology | $1,198,917 | $1,198,917 | - | - | 1.9% | |
| Pay: officers, directors, trustees, key employees | $1,009,201 | - | $1,009,201 | - | 1.6% | |
| Pension plan contributions | $752,109 | $654,096 | $98,013 | - | 1.2% | |
| Office expenses | $635,341 | $561,954 | $73,387 | - | 1.0% | |
| Travel | $533,314 | $450,379 | $82,935 | - | 0.8% | |
| Other (as described) | Non-Medical Supplies | $355,433 | $322,424 | $33,009 | - | 0.6% |
| All other expenses | $264,318 | $236,984 | $27,334 | - | 0.4% | |
| Conferences, conventions and meetings | $161,285 | $102,961 | $58,324 | - | 0.3% | |
| Advertising and promotion | $89,633 | $57,694 | $31,939 | - | 0.1% | |
| Other (as described) | Special Functions | $66,601 | $7,920 | $58,681 | - | 0.1% |
| Insurance | $35,160 | $22,248 | $12,912 | - | 0.1% | |
| Fees: lobbying | $12,321 | - | $12,321 | - | 0.0% | |
| Fees: legal | $3,177 | - | $3,177 | - | 0.0% | |
| Total | $63,008,893 | 100% |
2013 · Form 990 · $61,860,765 spent · pay $30,552,332 · grants $0 · events $110,070
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $24,066,103 | $21,427,225 | $2,638,878 | - | 38.9% | |
| Fees: other services | $13,594,429 | $10,979,052 | $2,615,377 | - | 22.0% | |
| Other (as described) | Medical Supplies | $5,948,392 | $5,948,392 | - | - | 9.6% |
| Depreciation and depletion | $4,280,861 | $4,280,861 | - | - | 6.9% | |
| Occupancy | $3,364,222 | $2,836,511 | $527,711 | - | 5.4% | |
| Other employee benefits | $3,053,922 | $2,648,821 | $405,101 | - | 4.9% | |
| Payroll taxes | $1,656,794 | $1,406,673 | $250,121 | - | 2.7% | |
| Information technology | $1,229,297 | $1,229,297 | - | - | 2.0% | |
| Other (as described) | Patent Reserve | $1,056,108 | - | $1,056,108 | - | 1.7% |
| Pay: officers, directors, trustees, key employees | $1,038,813 | - | $1,038,813 | - | 1.7% | |
| Pension plan contributions | $736,700 | $646,873 | $89,827 | - | 1.2% | |
| Office expenses | $551,144 | $479,093 | $72,051 | - | 0.9% | |
| Travel | $519,244 | $445,201 | $74,043 | - | 0.8% | |
| All other expenses | $249,617 | $175,161 | $74,456 | - | 0.4% | |
| Other (as described) | Non-Medical Supplies | $218,537 | $218,537 | - | - | 0.4% |
| Conferences, conventions and meetings | $110,070 | $77,033 | $33,037 | - | 0.2% | |
| Other (as described) | Special Functions | $80,033 | $21,793 | $58,240 | - | 0.1% |
| Advertising and promotion | $79,466 | $44,266 | $35,200 | - | 0.1% | |
| Insurance | $21,436 | - | $21,436 | - | 0.0% | |
| Fees: legal | $5,577 | - | $5,577 | - | 0.0% | |
| Total | $61,860,765 | 100% |
2012 · Form 990 · $62,159,368 spent · pay $28,999,392 · grants $0 · events $186,890
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $22,741,381 | $20,373,729 | $2,367,652 | - | 36.6% | |
| Fees: other services | $13,545,294 | $9,495,293 | $4,050,001 | - | 21.8% | |
| Other (as described) | Medical Supplies | $7,033,737 | $7,033,737 | - | - | 11.3% |
| Depreciation and depletion | $7,004,489 | $7,004,489 | - | - | 11.3% | |
| Other employee benefits | $2,805,729 | $2,445,949 | $359,780 | - | 4.5% | |
| Occupancy | $2,456,987 | $1,986,756 | $470,231 | - | 4.0% | |
| Payroll taxes | $1,501,148 | $1,308,478 | $192,670 | - | 2.4% | |
| Pay: officers, directors, trustees, key employees | $1,296,220 | - | $1,296,220 | - | 2.1% | |
| Information technology | $1,088,613 | $1,088,613 | - | - | 1.8% | |
| Office expenses | $994,093 | $756,200 | $237,893 | - | 1.6% | |
| Pension plan contributions | $654,914 | $536,531 | $118,383 | - | 1.1% | |
| Travel | $596,357 | $542,672 | $53,685 | - | 1.0% | |
| Conferences, conventions and meetings | $186,890 | $119,521 | $67,369 | - | 0.3% | |
| Other (as described) | Meals & Entertainment | $64,989 | $57,148 | $7,841 | - | 0.1% |
| Insurance | $42,923 | - | $42,923 | - | 0.1% | |
| Other (as described) | Dues & Memberships | $42,766 | $25,331 | $17,435 | - | 0.1% |
| Other (as described) | Special Functions | $40,445 | $33,958 | $6,487 | - | 0.1% |
| Advertising and promotion | $29,661 | $22,539 | $7,122 | - | 0.0% | |
| Fees: legal | $16,888 | - | $16,888 | - | 0.0% | |
| All other expenses | $15,844 | $15,844 | - | - | 0.0% | |
| Total | $62,159,368 | 100% |
2011 · Form 990 · $55,949,126 spent · pay $26,489,041 · grants $0 · events $129,970
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $20,539,113 | $18,028,096 | $2,511,017 | - | 36.7% | |
| Fees: other services | $13,492,345 | $10,445,413 | $3,046,932 | - | 24.1% | |
| Other (as described) | Medical Supplies | $6,614,670 | $6,575,741 | $38,929 | - | 11.8% |
| Depreciation and depletion | $3,657,445 | $3,657,445 | - | - | 6.5% | |
| Other employee benefits | $2,376,776 | $1,901,713 | $475,063 | - | 4.2% | |
| Occupancy | $1,994,312 | $1,558,695 | $435,617 | - | 3.6% | |
| Pay: officers, directors, trustees, key employees | $1,531,231 | - | $1,531,231 | - | 2.7% | |
| Payroll taxes | $1,413,004 | $1,130,799 | $282,205 | - | 2.5% | |
| Information technology | $1,384,064 | $1,384,064 | - | - | 2.5% | |
| Office expenses | $1,096,427 | $856,458 | $239,969 | - | 2.0% | |
| Travel | $702,883 | $620,194 | $82,689 | - | 1.3% | |
| Pension plan contributions | $628,917 | $476,226 | $152,691 | - | 1.1% | |
| Conferences, conventions and meetings | $129,970 | $86,476 | $43,494 | - | 0.2% | |
| Advertising and promotion | $103,016 | $87,025 | $15,991 | - | 0.2% | |
| Other (as described) | Dues & Memberships | $71,204 | $23,155 | $48,049 | - | 0.1% |
| Other (as described) | Meals & Entertainment | $57,885 | $52,072 | $5,813 | - | 0.1% |
| Insurance | $53,302 | - | $53,302 | - | 0.1% | |
| All other expenses | $51,827 | $40,309 | $11,518 | - | 0.1% | |
| Other (as described) | Bad Debt | $50,735 | $50,735 | - | - | 0.1% |
| Total | $55,949,126 | 100% |
2010 · Form 990 · $53,563,247 spent · pay $23,486,049 · grants $0 · events $254,094
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $18,685,060 | $16,290,038 | $2,395,022 | - | 34.9% | |
| Fees: other services | $15,506,113 | $12,081,825 | $3,424,288 | - | 28.9% | |
| Office expenses | $6,696,935 | $6,468,921 | $228,014 | - | 12.5% | |
| Depreciation and depletion | $3,738,111 | $3,738,111 | - | - | 7.0% | |
| Other employee benefits | $2,022,589 | $1,868,014 | $154,575 | - | 3.8% | |
| Occupancy | $1,854,685 | $1,630,225 | $224,460 | - | 3.5% | |
| Payroll taxes | $1,216,745 | $992,674 | $224,071 | - | 2.3% | |
| Information technology | $1,187,656 | $1,187,656 | - | - | 2.2% | |
| Pay: officers, directors, trustees, key employees | $1,001,233 | - | $1,001,233 | - | 1.9% | |
| Travel | $589,628 | $495,535 | $94,093 | - | 1.1% | |
| Pension plan contributions | $560,422 | $442,258 | $118,164 | - | 1.0% | |
| Conferences, conventions and meetings | $254,094 | $76,105 | $177,989 | - | 0.5% | |
| Advertising and promotion | $78,739 | $76,471 | $2,268 | - | 0.1% | |
| Other (as described) | Dues & Memberships | $51,137 | $28,047 | $23,090 | - | 0.1% |
| Other (as described) | Special Functions | $46,260 | $15,361 | $30,899 | - | 0.1% |
| Other (as described) | Meals & Entertainment | $43,518 | $32,709 | $10,809 | - | 0.1% |
| Insurance | $13,922 | - | $13,922 | - | 0.0% | |
| Fees: legal | $10,080 | - | $10,080 | - | 0.0% | |
| Other (as described) | Other Expenses | $6,320 | $6,320 | - | - | 0.0% |
| Total | $53,563,247 | 100% |
2009 · Form 990 · $46,418,959 spent · pay $22,099,041 · grants $0 · events $154,369
| Line | As described | Total | Program | Management | Fundraising | Share |
|---|---|---|---|---|---|---|
| Other salaries and wages | $17,755,452 | $15,152,208 | $2,603,244 | - | 38.3% | |
| Fees: other services | $10,796,424 | $7,919,140 | $2,877,284 | - | 23.3% | |
| Office expenses | $6,541,384 | $6,140,532 | $400,852 | - | 14.1% | |
| Depreciation and depletion | $3,218,654 | $3,218,654 | - | - | 6.9% | |
| Other employee benefits | $1,820,511 | $1,483,226 | $337,285 | - | 3.9% | |
| Occupancy | $1,756,071 | $1,480,851 | $275,220 | - | 3.8% | |
| Payroll taxes | $1,177,786 | $920,193 | $257,593 | - | 2.5% | |
| Information technology | $914,204 | - | $914,204 | - | 2.0% | |
| Pay: officers, directors, trustees, key employees | $803,630 | - | $803,630 | - | 1.7% | |
| Travel | $645,523 | $521,994 | $123,529 | - | 1.4% | |
| Pension plan contributions | $511,670 | $405,584 | $106,086 | - | 1.1% | |
| Conferences, conventions and meetings | $154,369 | $59,543 | $94,826 | - | 0.3% | |
| Other (as described) | Dues & Memberships | $70,088 | $25,351 | $44,737 | - | 0.2% |
| Advertising and promotion | $51,485 | $31,696 | $19,789 | - | 0.1% | |
| Other (as described) | Special Functions | $45,670 | $22,143 | $23,527 | - | 0.1% |
| Other (as described) | Meals & Entertainment | $43,839 | $34,615 | $9,224 | - | 0.1% |
| Other (as described) | Bad Debt | $36,644 | $36,644 | - | - | 0.1% |
| Fees: legal | $36,432 | - | $36,432 | - | 0.1% | |
| Pay: disqualified persons | $29,992 | - | $29,992 | - | 0.1% | |
| Other (as described) | Other Expenses | $9,131 | $3,390 | $5,741 | - | 0.0% |
| Total | $46,418,959 | 100% |
Federal grants and contracts
Awards from USAspending.gov to a recipient with this organization's name and zip code. Obligations by federal fiscal year (October to September); each award links to its page on usaspending.gov.
| Fiscal year | Grants and other assistance | Contracts | Awards |
|---|---|---|---|
| 2016 | $5,930,258 | $0 | 11 |
| 2015 | $4,567,405 | $0 | 10 |
| 2014 | $6,846,631 | $0 | 12 |
| 2013 | $11,537,655 | $0 | 18 |
| 2012 | $12,487,418 | $0 | 16 |
| 2011 | $12,405,760 | $0 | 14 |
| 2010 | $19,086,249 | $0 | 19 |
| 2009 | $18,005,597 | $0 | 14 |
| 2008 | $5,258,089 | $0 | 7 |
| 2007 | $6,848,207 | $0 | 9 |
Largest awards · 130 shown
| Year | Agency | Kind | Program | Description | Obligated |
|---|---|---|---|---|---|
| 2016 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | CENTER FOR LUPUS RESEARCH | $1,729,826 |
| 2016 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ASPIRIN AND CANCER PREVENTION IN LYNCH SYNDROME: FROM CELL TO POPULATION DATA | $555,997 |
| 2016 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | A SYSTEMS BIOLOGY APPROACH FOR PEDIATRIC AND ADULT AUTOIMMUNE DISEASES | $505,406 |
| 2016 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | PATIENT-CENTRIC RISK MODEL FOR MEDICATION SAFETY DURING CARE TRANSITIONS | $498,604 |
| 2016 | Administration on Aging | Grant or other assistance | ACL NATIONAL INSTITUTE ON DISABILITY, INDEPENDENT LIVING, AND REHABILITATI 93.433 | DISABILITY AND REHABILITATION RESEARCH PROGRAM | $447,500 |
| 2016 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | DC-ASGPR AS NOVEL TARGET FOR CONTROLLING GVHD AND ALLOGRAFT REJECTION | $392,000 |
| 2016 | Administration on Aging | Grant or other assistance | ACL NATIONAL INSTITUTE ON DISABILITY, INDEPENDENT LIVING, AND REHABILITATI 93.433 | FIELD INITIATED PROJECT: PROJECT WOWII: DEVELOPING AND TESTING A WEB-BASED INTERVENTION TO PROMOTE | $391,801 |
| 2016 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | THE BIOLOGY AND DIAGNOSIS OF HNPCC | $372,400 |
| 2016 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | MICRORNA BIOMARKERS FOR DETERMINING TREATMENT RESPONSE IN COLORECTAL CANCER | $360,913 |
| 2016 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | DEVELOPMENT OF MICRORNA BIOMARKERS FOR NONINVASIVE DETECTION OF COLORECTAL CANCER | $359,828 |
| 2016 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER | $315,983 |
| 2015 | Administration on Aging | Grant or other assistance | ACL NATIONAL INSTITUTE ON DISABILITY, INDEPENDENT LIVING, AND REHABILITATI 93.433 | DISABILITY AND REHABILITATION RESEARCH PROGRAM | $897,914 |
| 2015 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | A SYSTEMS BIOLOGY APPROACH FOR PEDIATRIC AND ADULT AUTOIMMUNE DISEASES | $648,199 |
| 2015 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ASPIRIN AND CANCER PREVENTION IN LYNCH SYNDROME: FROM CELL TO POPULATION DATA | $571,122 |
| 2015 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | PATIENT-CENTRIC RISK MODEL FOR MEDICATION SAFETY DURING CARE TRANSITIONS | $498,484 |
| 2015 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | DC-ASGPR AS NOVEL TARGET FOR CONTROLLING GVHD AND ALLOGRAFT REJECTION | $392,000 |
| 2015 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | BAYLOR CORE CLINICAL CENTER FOR THE CARDIOTHORACIC SURGICAL NETWORK | $382,306 |
| 2015 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | THE BIOLOGY AND DIAGNOSIS OF HNPCC | $372,400 |
| 2015 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | DEVELOPMENT OF MICRORNA BIOMARKERS FOR NONINVASIVE DETECTION OF COLORECTAL CANCER | $360,402 |
| 2015 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER | $320,751 |
| 2015 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | SYSTEMS ANALYSIS VACCINE RESPONSES IN HEALTHY AND HYPORESPONSIVE HUMANS | $123,827 |
| 2014 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | SYSTEMS ANALYSIS VACCINE RESPONSES IN HEALTHY AND HYPORESPONSIVE HUMANS | $3,206,850 |
| 2014 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | A SYSTEMS BIOLOGY APPROACH FOR PEDIATRIC AND ADULT AUTOIMMUNE DISEASES | $726,556 |
| 2014 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | ASPIRIN AND CANCER PREVENTION IN LYNCH SYNDROME: FROM CELL TO POPULATION DATA | $595,990 |
| 2014 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | CHARACTERIZING DEXD/H BOX HELICASES AS VIRAL SENSORS IN HUMAN DENDRITIC CELLS | $392,000 |
| 2014 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | UNDERSTANDING THE EARLY AND LATE ENDOSOMAL TLR9-MEDIATED RESPONSES TO VIRAL DNA. | $392,000 |
| 2014 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | BAYLOR CORE CLINICAL CENTER FOR THE CARDIOTHORACIC SURGICAL NETWORK | $380,365 |
| 2014 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | DC-ASGPR AS NOVEL TARGET FOR CONTROLLING GVHD AND ALLOGRAFT REJECTION | $330,586 |
| 2014 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | METHYLATION BIOMARKER DEVELOPMENT FOR NONINVASIVE DETECTION OF COLORECTAL CANCER | $327,289 |
| 2014 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | JC VIRUS AND TUMOR FORMATION IN THE HUMAN COLON | $259,352 |
| 2014 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE AND FUNCTION OF PROHIBITIN IN INTESTINAL INFLAMMATION | $133,057 |
| 2014 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MAINTENANCE OF INTESTINAL EPITHELIAL CELL HOMEOSTASIS BY PROHIBITIN | $78,400 |
| 2014 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | ANALYSIS AND DISSEMINATION OF PATIENT-CENTERED OUTCOMES AND ITS IMPACT ON PATIENT | $24,186 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | HUMAN DENDRITIC CELLS AND IN VIVO IMMUNITY TO BIOTHREAT | $4,362,911 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | SYSTEMS ANALYSIS VACCINE RESPONSES IN HEALTHY AND HYPORESPONSIVE HUMANS | $3,059,835 |
| 2013 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | NEW-ONSET POST-CABG ATRIAL FIBRILLATION | $711,867 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | A SYSTEMS BIOLOGY APPROACH FOR PEDIATRIC AND ADULT AUTOIMMUNE DISEASES | $629,850 |
| 2013 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | BAYLOR CORE CLINICAL CENTER FOR THE CARDIOTHORACIC SURGICAL NETWORK | $372,486 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | CHARACTERIZING DEXD/H BOX HELICASES AS VIRAL SENSORS IN HUMAN DENDRITIC CELLS | $368,480 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | UNDERSTANDING THE EARLY AND LATE ENDOSOMAL TLR9-MEDIATED RESPONSES TO VIRAL DNA. | $368,480 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | DC-ASGPR AS A NOVEL TARGET FOR CONTROLLING GVHD AND ALLOGRAFT REJECTION | $368,480 |
| 2013 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | THE BIOLOGY AND DIAGNOSIS OF HNPCC | $312,561 |
| 2013 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | IMPLEMENTING A BUNDLE FOR INTENSIVE CARE UNIT DELIRIUM-THE IBID PROJECT | $291,506 |
| 2013 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | JC VIRUS AND TUMOR FORMATION IN THE HUMAN COLON | $251,332 |
| 2013 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | CONTROLLING ALLERGEN-SPECIFIC TH2-TYPE RESPONSES BY TARGETING DC SURFACE LECTINS | $232,885 |
| 2013 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | VACCINATION WITH IL-15 DC TO GENERATE MELANOMA-SPECIFIC PROTECTIVE MEMORY T CELLS | $217,043 |
| 2013 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE AND FUNCTION OF PROHIBITIN IN INTESTINAL INFLAMMATION | $146,459 |
| 2013 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | ANALYSIS AND DISSEMINATION OF PATIENT-CENTERED OUTCOMES AND ITS IMPACT ON PATIENT | $145,259 |
| 2013 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | COSTS OF TRANSFORMING ESTABLISHED PRIMARY CARE PRACTICES TO PATIENT-CENTERED MEDI | $99,821 |
| 2013 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | MAINTENANCE OF INTESTINAL EPITHELIAL CELL HOMEOSTASIS BY PROHIBITIN | $78,400 |
| 2013 | Health Resources and Services Administration | Grant or other assistance | AFFORDABLE CARE ACT (ACA) PRIMARY CARE RESIDENCY EXPANSION PROGRAM 93.510 | AFFORDABLE CARE ACT: PRIMARY CARE RESIDENCY EXPANSION | -$480,000 |
| 2012 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | HUMAN DENDRITIC CELLS AND IN VIVO IMMUNITY TO BIOTHREAT | $4,668,879 |
| 2012 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | SYSTEMS ANALYSIS VACCINE RESPONSES IN HEALTHY AND HYPORESPONSIVE HUMANS | $3,034,833 |
| 2012 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | NEW-ONSET POST-CABG ATRIAL FIBRILLATION | $763,813 |
| 2012 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | A SYSTEMS BIOLOGY APPROACH FOR PEDIATRIC AND ADULT AUTOIMMUNE DISEASES | $710,160 |
| 2012 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | VACCINATION WITH IL-15 DC TO GENERATE MELANOMA-SPECIFIC PROTECTIVE MEMORY T CELLS | $395,213 |
| 2012 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | UNDERSTANDING THE EARLY AND LATE ENDOSOMAL TLR9-MEDIATED RESPONSES TO VIRAL DNA. | $392,000 |
| 2012 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | CHARACTERIZING DEXD/H BOX HELICASES AS VIRAL SENSORS IN HUMAN DENDRITIC CELLS | $389,361 |
| 2012 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | THE BIOLOGY AND DIAGNOSIS OF HNPCC | $332,512 |
| 2012 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | USE OF MICROARRAYS TO UNDERSTAND SYSTEMIC ARTHRITIS | $326,595 |
| 2012 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | IMPLEMENTING A BUNDLE FOR INTENSIVE CARE UNIT DELIRIUM-THE IBID PROJECT | $295,915 |
| 2012 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | JC VIRUS AND TUMOR FORMATION IN THE HUMAN COLON | $267,374 |
| 2012 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | A LARGE POPULATION-BASED STUDY OF SURGERY FOR ABDOMINAL AORTIC ANEURYSMS | $232,136 |
| 2012 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DUCTAL PRESERVATION SOLUTIONS AND QUANTITY AND QUALITY OF ISOLATED HUMAN ISLETS | $196,000 |
| 2012 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | CONTROLLING ALLERGEN-SPECIFIC TH2-TYPE RESPONSES BY TARGETING DC SURFACE LECTINS | $196,000 |
| 2012 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE AND FUNCTION OF PROHIBITIN IN INTESTINAL INFLAMMATION | $146,459 |
| 2012 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | IMPACT OF HEALTH IT IMPLEMENTATION ON DIABETES PROCESS AND OUTCOME MEASURES | $140,168 |
| 2011 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | HUMAN DENDRITIC CELLS AND IN VIVO IMMUNITY TO BIOTHREAT | $4,764,161 |
| 2011 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | SYSTEMS ANALYSIS VACCINE RESPONSES IN HEALTHY AND HYPORESPONSIVE HUMANS | $3,077,917 |
| 2011 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | NEW-ONSET POST-CABG ATRIAL FIBRILLATION | $818,840 |
| 2011 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | A SYSTEMS BIOLOGY APPROACH FOR PEDIATRIC AND ADULT AUTOIMMUNE DISEASES | $786,121 |
| 2011 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DIVERSIFICATION OF CYTOTOXIC EFFECTOR CELLS VIA LPS-ACTIVATED DCS | $580,820 |
| 2011 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | VACCINATION WITH IL-15 DC TO GENERATE MELANOMA-SPECIFIC PROTECTIVE MEMORY T CELLS | $389,282 |
| 2011 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | THE BIOLOGY AND DIAGNOSIS OF HNPCC | $332,512 |
| 2011 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | USE OF MICROARRAYS TO UNDERSTAND SYSTEMIC ARTHRITIS | $326,595 |
| 2011 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | FROM NSQIP TO TQIP - TRAUMA QUALITY IMPROVEMENT PROJECT | $288,789 |
| 2011 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | JC VIRUS AND TUMOR FORMATION IN THE HUMAN COLON | $267,374 |
| 2011 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | DUCTAL PRESERVATION SOLUTIONS AND QUANTITY AND QUALITY OF ISOLATED HUMAN ISLETS | $235,200 |
| 2011 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | A LARGE POPULATION-BASED STUDY OF SURGERY FOR ABDOMINAL AORTIC ANEURYSMS | $231,873 |
| 2011 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | IMPACT OF HEALTH IT IMPLEMENTATION ON DIABETES PROCESS AND OUTCOME MEASURES | $159,817 |
| 2011 | National Institutes of Health | Grant or other assistance | DIABETES, DIGESTIVE, AND KIDNEY DISEASES EXTRAMURAL RESEARCH 93.847 | ROLE AND FUNCTION OF PROHIBITIN IN INTESTINAL INFLAMMATION | $146,459 |
| 2010 | National Institutes of Health | Grant or other assistance | TRANS-NIH RECOVERY ACT RESEARCH SUPPORT 93.701 | HUMAN DENDRITIC CELLS AND IN VIVO IMMUNITY TO BIOTHREAT | $6,134,345 |
| 2010 | National Institutes of Health | Grant or other assistance | TRANS-NIH RECOVERY ACT RESEARCH SUPPORT 93.701 | SYSTEMS ANALYSIS VACCINE RESPONSES IN HEALTHY AND HYPORESPONSIVE HUMANS | $4,499,507 |
| 2010 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | BLOOD TRANSCRIPTIONAL BIOMARKER PROFILES FOR CATEGORY B PATHOGENS | $1,183,558 |
| 2010 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | CENTER FOR LUPUS RESEARCH | $1,033,649 |
| 2010 | Health Resources and Services Administration | Grant or other assistance | AFFORDABLE CARE ACT (ACA) PRIMARY CARE RESIDENCY EXPANSION PROGRAM 93.510 | AFFORDABLE CARE ACT: PRIMARY CARE RESIDENCY EXPANSION | $960,000 |
| 2010 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | A SYSTEMS BIOLOGY APPROACH FOR PEDIATRIC AND ADULT AUTOIMMUNE DISEASES | $694,982 |
| 2010 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DIVERSIFICATION OF CYTOTOXIC EFFECTOR CELLS VIA LPS-ACTIVATED DCS | $578,305 |
| 2010 | National Institutes of Health | Grant or other assistance | TRANS-NIH RECOVERY ACT RESEARCH SUPPORT 93.701 | TARGETING DENDRITIC CELL SUBSETS IN HUMAN VAGINA TO ELICIT LOCAL IMMUNITY | $499,875 |
| 2010 | National Institutes of Health | Grant or other assistance | TRANS-NIH RECOVERY ACT RESEARCH SUPPORT 93.701 | IMMUNOTHERAPEUTIC HPV CANCER VACCINES THAT TARGET LANGERHANS CELLS | $499,606 |
| 2010 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | VACCINATION WITH IL-15 DC TO GENERATE MELANOMA-SPECIFIC PROTECTIVE MEMORY T CELLS | $409,401 |
| 2010 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | ALTERED CD8+ T CELL COMPARTMENT IN SLE PATIENTS | $359,529 |
| 2010 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | THE BIOLOGY AND DIAGNOSIS OF HNPCC | $342,796 |
| 2010 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | USE OF MICROARRAYS TO UNDERSTAND SYSTEMIC ARTHRITIS | $340,203 |
| 2010 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | FROM NSQIP TO TQIP - TRAUMA QUALITY IMPROVEMENT PROJECT | $321,106 |
| 2010 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | JC VIRUS AND TUMOR FORMATION IN THE HUMAN COLON | $275,643 |
| 2010 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | IMPROVING THE SAFETY OF PRIMARY CARE BY MEASURING ADVERSE EVENTS AND IMPROVEMENT | $274,961 |
| 2010 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | GENOME-WIDE PROFILING OF IMMUNE RESPONSIVENESS IN PATIENTS WITH PRIMARY IMMUNODEF | $240,500 |
| 2010 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | A LARGE POPULATION-BASED STUDY OF SURGERY FOR ABDOMINAL AORTIC ANEURYSMS | $238,283 |
| 2010 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IMPROVING THE EFFICACY OF DENDRITIC CELL VACCINES | $200,000 |
| 2009 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | HUMAN DENDRITIC CELLS AND IN VIVO IMMUNITY TO BIOTHREAT | $11,801,908 |
| 2009 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | BLOOD TRANSCRIPTIONAL BIOMARKER PROFILES FOR CATEGORY B PATHOGENS | $1,213,173 |
| 2009 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | CENTER FOR LUPUS RESEARCH | $1,187,247 |
| 2009 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | A SYSTEMS BIOLOGY APPROACH FOR PEDIATRIC AND ADULT AUTOIMMUNE DISEASES | $702,000 |
| 2009 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DIVERSIFICATION OF CYTOTOXIC EFFECTOR CELLS VIA LPS-ACTIVATED DCS | $546,210 |
| 2009 | National Institutes of Health | Grant or other assistance | TRANS-NIH RECOVERY ACT RESEARCH SUPPORT 93.701 | IMMUNOTHERAPEUTIC HPV CANCER VACCINES THAT TARGET LANGERHANS CELLS | $480,981 |
| 2009 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | ALTERED CD8+ T CELL COMPARTMENT IN SLE PATIENTS | $363,160 |
| 2009 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | THE BIOLOGY AND DIAGNOSIS OF HNPCC | $342,796 |
| 2009 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | USE OF MICROARRAYS TO UNDERSTAND SYSTEMIC ARTHRITIS | $340,840 |
| 2009 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | IMPROVING THE SAFETY OF PRIMARY CARE BY MEASURING ADVERSE EVENTS AND IMPROVEMENT | $293,733 |
| 2009 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | FROM NSQIP TO TQIP - TRAUMA QUALITY IMPROVEMENT PROJECT | $277,594 |
| 2009 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IMPROVING THE EFFICACY OF DENDRITIC CELL VACCINES | $200,000 |
| 2009 | National Institutes of Health | Grant or other assistance | TRANS-NIH RECOVERY ACT RESEARCH SUPPORT 93.701 | TARGETING PDCS FOR THE GENERATION OF EFFECTIVE ANTI-HCV CD8+ T-CELL IMMUNITY | $156,000 |
| 2009 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | IMPACT OF HEALTH IT ON PRIMARY CARE WORK-FLOW AND FINANCIAL MEASURES | $99,955 |
| 2008 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | HUMAN DENDRITIC CELLS AND IN VIVO IMMUNITY TO BIOTHREAT | $3,141,637 |
| 2008 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | DIVERSIFICATION OF CYTOTOXIC EFFECTOR CELLS VIA LPS-ACTIVATED DCS | $526,521 |
| 2008 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | USE OF MICROARRAYS TO UNDERSTAND SYSTEMIC ARTHRITIS | $371,080 |
| 2008 | Health Resources and Services Administration | Grant or other assistance | HEALTH CARE AND OTHER FACILITIES 93.887 | HEALTH CARE AND OTHER FACILITIES | $333,638 |
| 2008 | National Institutes of Health | Grant or other assistance | CANCER DETECTION AND DIAGNOSIS RESEARCH 93.394 | THE BIOLOGY AND DIAGNOSIS OF HNPCC | $326,412 |
| 2008 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | IMPROVING THE SAFETY OF PRIMARY CARE BY MEASURING ADVERSE EVENTS AND IMPROVEMENT | $298,525 |
| 2008 | National Institutes of Health | Grant or other assistance | CANCER CAUSE AND PREVENTION RESEARCH 93.393 | JC VIRUS AND TUMOR FORMATION IN THE HUMAN COLON | $260,276 |
| 2007 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | HUMAN DENDRITIC CELLS AND IN VIVO IMMUNITY TO BIOTHREAT | $3,141,637 |
| 2007 | National Institutes of Health | Grant or other assistance | ARTHRITIS, MUSCULOSKELETAL AND SKIN DISEASES RESEARCH 93.846 | CENTER FOR LUPUS RESEARCH | $1,499,729 |
| 2007 | National Institutes of Health | Grant or other assistance | CANCER TREATMENT RESEARCH 93.395 | IMPROVING THE EFFICACY OF DENDRITIC CELL VACCINES | $978,697 |
| 2007 | National Institutes of Health | Grant or other assistance | ALLERGY, IMMUNOLOGY AND TRANSPLANTATION RESEARCH 93.855 | ALTERED CD8+ T CELL COMPARTMENT IN SLE PATIENTS | $370,194 |
| 2007 | National Institutes of Health | Grant or other assistance | CANCER BIOLOGY RESEARCH 93.396 | SUBPOPULATIONS OF HUMAN DENDRITIC CELLS | $292,811 |
| 2007 | National Institutes of Health | Grant or other assistance | CARDIOVASCULAR DISEASES RESEARCH 93.837 | FUNCTIONAL MR IN ISCHEMIC CARDIOMYOPATHY | $236,605 |
| 2007 | Agency for Healthcare Research and Quality | Grant or other assistance | RESEARCH ON HEALTHCARE COSTS, QUALITY AND OUTCOMES 93.226 | ADVERSE EVENT DIRECTED ANALYSIS IN AMBULATORY PRIMARY CARE | $199,986 |
| 2007 | National Institutes of Health | Grant or other assistance | CANCER RESEARCH MANPOWER 93.398 | A PULL-PUSH STRATEGY FOR LYMPHOMA IMMUNOTHERAPY | $128,547 |
| 2007 | National Institutes of Health | Grant or other assistance | RESEARCH AND TRAINING IN COMPLEMENTARY AND ALTERNATIVE MEDICINE 93.213 | EFFECT OF S-ADENOSYLMETHIONINE ON BLOOD HOMOCYSTEINE | $1 |
State business registration
- BAYLOR RESEARCH INSTITUTE TX, CN, Active franchise taxpayer (SOS status A), formed 1982-10-10
The same business name in the same state, from the state’s official registry data.
Patents
79 US patents filed in the last 20 years.
- BAYLOR RESEARCH INSTITUTE 79 patents, 2009-11-24 to 2026-08-25 EXACT high confidence: identical full name and state
| Patent | Title | Granted | Source |
|---|---|---|---|
| US 12714745 | Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) | 2026-08-25 | PTBLXML, file of 2026-08-25 |
| US 12576147 | Recombinant proteins with CD40 activating properties | 2026-03-17 | PTBLXML, file of 2026-03-17 |
| US 12214034 | Vaccines against HPV and HPV-related diseases | 2025-02-04 | PVGPATDIS, file of 2026-04-10 |
| US 12016915 | Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR) | 2024-06-25 | PVGPATDIS, file of 2026-04-10 |
| US 11957734 | Methods and compositions for treating autoimmune and inflammatory conditions | 2024-04-16 | PVGPATDIS, file of 2026-04-10 |
| US 11806390 | Fusion proteins comprising an anti-CD40 antibody and cancer antigens | 2023-11-07 | PVGPATDIS, file of 2026-04-10 |
| US 11717567 | Vaccines against HPV and HPV-related diseases | 2023-08-08 | PVGPATDIS, file of 2026-04-10 |
| US 11666286 | Classification of polyps using learned image analysis | 2023-06-06 | PVGPATDIS, file of 2026-04-10 |
| US 11618926 | Methods for diagnosing, prognosing, and treating colorectal cancer using biomarker expression | 2023-04-04 | PVGPATDIS, file of 2026-04-10 |
| US 11571365 | Intraluminal tubes with deployable structures and related methods | 2023-02-07 | PVGPATDIS, file of 2026-04-10 |
The newest patents of the PatentsView assignees above, matched to this record by name (and state).
Comments